Omega Protein (OME) 10-Q 17 Nov 14 2014 Q3 Quarterly report Financial data

Document_And_Entity_Informatio

Document And Entity Information	9 Months Ended
	Sep. 30, 2014	Nov. 12, 2014
Document and Entity Information [Abstract]	'	'
Entity Registrant Name	'Omega Protein Corp	'
Document Type	'10-Q	'
Current Fiscal Year End Date	'--12-31	'
Entity Common Stock, Shares Outstanding	'	21,587,733
Amendment Flag	'false	'
Entity Central Index Key	'0001053650	'
Entity Current Reporting Status	'Yes	'
Entity Voluntary Filers	'No	'
Entity Filer Category	'Accelerated Filer	'
Entity Well-known Seasoned Issuer	'No	'
Document Period End Date	30-Sep-14	'
Document Fiscal Year Focus	'2014	'
Document Fiscal Period Focus	'Q3	'

Unaudited_Condensed_Consolidat

Unaudited Condensed Consolidated Balance Sheet (USD $)	Sep. 30, 2014	Dec. 31, 2013
In Thousands, unless otherwise specified
Current assets:	'	'
Cash and cash equivalents	$1,714	$34,059
Receivables, net	46,099	21,140
Inventories	107,919	94,339
Deferred tax asset, net	1,772	1,062
Prepaid expenses and other current assets	5,911	3,915
Total current assets	163,415	154,515
Other assets, net	2,666	5,234
Property, plant and equipment, net	165,529	144,113
Goodwill	50,658	19,600
Other intangible assets, net	21,388	7,932
Total assets	403,656	331,394
Current liabilities:	'	'
Current maturities of long-term debt	14,157	3,112
Accounts payable	14,893	5,380
Accrued liabilities	38,448	29,145
Total current liabilities	67,498	37,637
Long-term debt, net of current maturities	40,770	21,130
Deferred tax liability, net	23,773	19,351
Pension liabilities, net	2,516	4,117
Other long-term liabilities	2,414	1,929
Total liabilities	136,971	84,164
Commitments and contingencies	'	'
Preferred stock, $0.01 par value; 10,000,000 authorized shares; none issued	0	0
Common Stock, $0.01 par value; 80,000,000 authorized shares; 21,587,751 and 20,804,189 shares issued and 21,578,733 and 20,804,189 shares outstanding at September 30, 2014 and December 31, 2013, respectively	208	203
Capital in excess of par value	141,153	136,428
Retained earnings	132,070	116,807
Treasury stock, at cost – 9,018 shares	-119	'
Accumulated other comprehensive loss	-6,627	-6,208
Total stockholders’ equity	266,685	247,230
Total liabilities and stockholders’ equity	$403,656	$331,394

Unaudited_Condensed_Consolidat1

Unaudited Condensed Consolidated Balance Sheet (Parentheticals) (USD $)	Sep. 30, 2014	Dec. 31, 2013
Preferred stock par value (in Dollars per share)	$0.01	$0.01
Preferred stock, shares authorized	10,000,000	10,000,000
Preferred stock, shares issued	0	0
Common Stock, par value (in Dollars per share)	$0.01	$0.01
Common Stock, shares authorized	80,000,000	80,000,000
Common Stock, shares issued	21,587,751	20,804,189
Common Stock, shares outstanding	21,578,733	20,804,189
Treasury stock, shares	9,018	'

Unaudited_Condensed_Consolidat2

Unaudited Condensed Consolidated Statement of Comprehensive Income (USD $)	3 Months Ended				9 Months Ended
In Thousands, except Per Share data, unless otherwise specified	Sep. 30, 2014		Sep. 30, 2013		Sep. 30, 2014		Sep. 30, 2013
Revenues	$70,764	[1]	$87,620	[2]	$206,177	[3]	$178,320	[4]
Cost of sales	56,586		58,200		151,082		123,520
Gross profit	14,178		29,420		55,095		54,800
Selling, general, and administrative expense	10,216		6,930		22,835		19,403
Research and development expense	608		650		1,636		1,770
Impairment of intangible assets	'		80		'		80
Operating income	1,799		21,921		24,897		33,334
Interest income	4		5		17		15
Interest expense	-365		-483		-747		-1,356
Gain on foreign currency	272		'		272		'
Other expense, net	-39		-104		-213		-285
Income before income taxes	1,671		21,339		24,226		31,708
Provision for income taxes	1,012		7,377		8,963		10,911
Net income	659		13,962		15,263		20,797
Foreign currency translation adjustment net of tax benefit of $243, $0, $243 and $0, respectively	-449		'		-449		'
Energy swap adjustment, net of tax (expense) benefit of $204, ($54), $224 and $2, respectively	-379		101		-416		-5
Pension benefits adjustment, net of tax expense of $80, $135, $240 and $405, respectively	149		251		446		753
Comprehensive income (loss)	-20		14,314		14,844		21,545
Basic earnings per share (See Note 14) (in Dollars per share)	$0.03		$0.68		$0.73		$1.03
Weighted average common shares outstanding (in Shares)	20,637		20,150		20,474		19,801
Diluted earnings per share (See Note 14) (in Dollars per share)	$0.03		$0.66		$0.70		$0.99
Weighted average common shares and potential common share equivalents outstanding (in Shares)	21,258		20,762		21,122		20,520
Plant Closure [Member]	'		'		'		'
Loss (gain) on disposition of assets	1,543		'		5,482		'
Disposal of Assets [Member]	'		'		'		'
Loss (gain) on disposition of assets	$12		($161)		$245		$213
[1]	Excludes revenue from internal customers of $0.4 million for fish oil that was transferred from the animal nutrition segment to the human nutrition segment at cost.
[2]	Excludes revenue from internal customers of $0.3 million for fish oil that was transferred from the animal nutrition segment to the human nutrition segment at cost.
[3]	Excludes revenue from internal customers of $1.8 million for fish oil that was transferred from the animal nutrition segment to the human nutrition segment at cost.
[4]	Excludes revenue from internal customers of $1.3 million for fish oil that was transferred from the animal nutrition segment to the human nutrition segment at cost.

Unaudited_Condensed_Consolidat3

Unaudited Condensed Consolidated Statement of Comprehensive Income (Parentheticals) (USD $)	3 Months Ended		9 Months Ended
In Thousands, unless otherwise specified	Sep. 30, 2014	Sep. 30, 2013	Sep. 30, 2014	Sep. 30, 2013
Foreign currency translation adjustment, tax benefit	$243	$0	$243	$0
Energy swap adjustment, tax benefit	204	-54	224	2
Pension benefits adjustment, tax expense	$80	$135	$240	$405

Unaudited_Condensed_Consolidat4

Unaudited Condensed Consolidated Statement of Cash Flows (USD $)	9 Months Ended
In Thousands, unless otherwise specified	Sep. 30, 2014	Sep. 30, 2013
Cash flows from operating activities:	'	'
Net income	$15,263	$20,797
Depreciation and amortization	16,072	15,627
Impairment of intangible assets	'	80
Provisions for losses on receivables	36	36
Share based compensation	1,688	1,461
Deferred income taxes	-936	5,074
Unrealized (gain) on foreign currency fluctuations, net	-272	'
Changes in assets and liabilities:	'	'
Receivables	-9,861	-604
Inventories	6,331	-22,700
Prepaid expenses and other current assets	-602	-1,782
Other assets	1,454	5,409
Accounts payable	-1,880	938
Accrued liabilities	9,030	2,538
Pension liability, net	-1,063	-622
Other long term liabilities	-21	182
Net cash provided by operating activities	37,539	26,647
Cash flows from investing activities:	'	'
Proceeds from disposition of assets	257	313
Land and building purchased in capital lease extinguishment	'	-5,005
Capital expenditures	-36,254	-18,009
Net cash used in investing activities	-82,385	-49,377
Cash flows from financing activities:	'	'
Principal payments of long-term debt	-14,776	-2,316
Proceeds from long-term debt	24,000	'
Principal payments of capital lease obligation	'	-309
Purchase treasury stock at cost	-119	'
Proceeds from stock options exercised	2,245	3,048
Excess tax benefit of stock options exercised	1,151	1,147
Net cash provided by (used in) financing activities	12,501	1,570
Net increase (decrease) in cash and cash equivalents	-32,345	-21,160
Cash and cash equivalents at beginning of year	34,059	55,998
Cash and cash equivalents at end of period	1,714	34,838
Wisconsin Specialty Protein [Member]	'	'
Cash flows from investing activities:	'	'
Acquisitions, net of cash acquired	'	-26,676
Bioriginal [Member]	'	'
Cash flows from investing activities:	'	'
Acquisitions, net of cash acquired	-46,388	'
Plant Closure [Member]	'	'
Cash flows from operating activities:	'	'
Loss on plant closure	2,055	'
Loss (gain) on disposal of assets	5,482	'
Disposal of Assets [Member]	'	'
Cash flows from operating activities:	'	'
Loss (gain) on disposal of assets	$245	$213

Note_1_Significant_Accounting_

Note 1 - Significant Accounting Policies Summary of Operations and Basis of Presentation	9 Months Ended
	Sep. 30, 2014
Accounting Policies [Abstract]	'
Significant Accounting Policies [Text Block]	'
	NOTE 1.	SIGNIFICANT ACCOUNTING POLICIES
		SUMMARY OF OPERATIONS AND BASIS OF PRESENTATION
	Business Description
	Omega Protein Corporation (the “Company”) is a nutritional product company that develops, produces and delivers healthy products throughout the world to improve the nutritional integrity of foods, dietary supplements and animal feeds. The Company operates through two industry segments: animal nutrition and human nutrition.
	The animal nutrition segment is comprised primarily of two subsidiaries: Omega Protein, Inc. (“Omega Protein”) and Omega Shipyard, Inc. (“Omega Shipyard”). Omega Protein, the Company’s principal operating subsidiary, is the successor to a business conducted since 1913. Omega Protein produces and markets a variety of products produced from menhaden (a herring-like species of fish found in commercial quantities in the U.S. coastal waters of the Atlantic Ocean and Gulf of Mexico), including regular grade and value-added specialty fish meals, crude and refined fish oils and fish solubles. Omega Protein’s fish meal products are primarily used as a protein ingredient in animal feed for swine, aquaculture and household pets. Fish oil is utilized primarily for animal and aquaculture feeds, as well as additives to human food products and dietary supplements. Omega Protein’s fish solubles are sold primarily to livestock feed manufacturers, aquaculture feed manufacturers and for use as an organic fertilizer. Omega Protein’s business is seasonal in nature and generally has higher revenues during the third quarter of each fiscal year. A portion of Omega Protein’s production is transferred to the human nutrition segment where it is further processed and sold. Omega Shipyard owns and operates a drydock facility in Moss Point, Mississippi that is used to provide shoreside maintenance for Omega Protein’s fishing fleet and, subject to outside demand and excess capacity, occasionally for third-party vessels.
	The human nutrition segment, which operates under the names Nutegrity and Bioriginal, has three primary product lines: protein products, specialty oils and essential fatty acids and other nutraceutical ingredients. Nutegrity is comprised primarily of three subsidiaries: Cyvex Nutrition, Inc. (“Cyvex”), InCon Processing, L.L.C. (“InCon”), and Wisconsin Specialty Protein, L.L.C. (“WSP”). Cyvex, acquired by the Company in December 2010, is located in Irvine, California and is an ingredient provider in the nutraceutical industry. InCon, acquired by the Company in September 2011, is located in Batavia, Illinois and is a specialty processor that utilizes molecular distillation technology to concentrate Omega-3 fish oils and, subject to outside demand and excess capacity, a variety of other compound products for third-party tolling customers. WSP, acquired by the Company in February 2013, is a manufacturer and marketer of specialty dairy and other protein products headquartered in Madison, Wisconsin and operates a production facility in Reedsburg, Wisconsin. See Note 3 – Acquisition of Wisconsin Specialty Protein, L.L.C. for additional information related to the Company’s acquisition of WSP.
	Bioriginal Food & Science Corp. (“Bioriginal”), acquired by the Company in September 2014 and headquartered in Saskatoon, Canada with additional operations in the Netherlands, is a supplier of plant and marine based specialty oils and essential fatty acids to the food and nutraceutical industries. See Note 2 – Acquisition of Bioriginal Food & Science Corp. for additional information related to the Company’s acquisition of Bioriginal.
	Basis of Presentation
	These interim financial statements of the Company have been prepared in accordance with accounting principles generally accepted in the United States of America for interim financial information, the instructions to Quarterly Report on Form 10-Q and Rule 10-01 of Regulation S-X. Accordingly, certain information and footnote disclosures normally provided have been omitted. The interim financial statements should be read in conjunction with our Annual Report on Form 10-K for the year ended December 31, 2013. The year end condensed balance sheet data was derived from audited financial statements, but does not include all disclosures required by accounting principles generally accepted in the United States of America.
	In the opinion of management the accompanying unaudited condensed consolidated financial statements reflect all adjustments (consisting only of normal recurring adjustments) necessary for a fair statement of the Company’s consolidated financial position as of September 30, 2014, and the results of its operations for the three month and nine month periods ended September 30, 2014 and 2013 and its cash flows for the nine month periods ended September 30, 2014 and 2013. Operating results for interim periods are not necessarily indicative of the results that may be expected for the year ending December 31, 2014.
	Consolidation
	The consolidated financial statements include the accounts of Omega Protein Corporation and its wholly owned subsidiaries. All significant intercompany accounts and transactions have been eliminated in consolidation.
	Financial Statement Preparation
	The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the Company’s financial statements and the accompanying notes and the reported amounts of revenues and expenses during the reporting period. Actual amounts, when available, could differ from those estimates and those differences could have a material effect on the financial statements.
	Revenue Recognition
	The Company derives revenue principally from the sales of a variety of protein and oil products derived from menhaden. In addition and as a result of its acquisitions of Cyvex, InCon, WSP and Bioriginal the Company’s revenues include sales of dietary supplement and food ingredients and products. The Company recognizes revenue for the sale of its products when price is established, collectability is reasonably assured and risk and rewards of ownership of its products and title are transferred to the customer.
	Shipping and Handling
	Amounts billed to customers associated with shipping and handling are included in revenues and the related costs are included in cost of sales.
	Inventories
	During the off-seasons, in connection with the upcoming fishing seasons, Omega Protein incurs costs (e.g., plant and vessel related labor, utilities, rent, repairs, and depreciation) that are directly related to Omega Protein’s infrastructure. These costs accumulate in inventory and are applied as elements of the cost of production of Omega Protein’s products throughout the fishing season ratably based on Omega Protein’s monthly units of production and the expected total units of production for the season.
	Any costs incurred during abnormal downtime related to activity at Omega Protein’s plants are charged to expense as incurred.
	Energy Swap Agreements
	The Company does not enter into financial instruments for trading or speculative purposes. Omega Protein enters into energy swap agreements to manage portions of its cash flow exposure related to the volatility of natural gas, diesel and propane energy prices for its fish meal and fish oil production operations. The swaps effectively fix pricing for the quantities listed below during the consumption periods.
											(in thousands)
	Energy Swap		Consumption		Quantity		Price				Energy Swap				Deferred Tax
			Period				Per				Asset/(Liability)				Asset/(Liability)
							Unit				as of				as of
											September 30,				September 30,
											2014				2014
	Diesel - NYMEX Heating Oil Swap		Oct. – Nov., 2014		370,515 Gallons		$	2.92			$	(101	)		$	35
	Natural Gas - NYMEX Natural Gas Swap		Oct., 2014		41,258 MMBTUs		$	3.86				11				(4	)
	Propane – Natural Gas Liquids Swap		Oct. – Nov., 2014		190,000 Gallons		$	1.09				(9	)			3
	Diesel - NYMEX Heating Oil Swap		Apr. – Nov., 2015		1,667,116 Gallons		$	2.83				(237	)			83
	Natural Gas - NYMEX Natural Gas Swap		Apr. – Oct., 2015		114,000 MMBTUs		$	4.09				(28	)			10
											$	(364	)		$	127
											(in thousands)
	Energy Swap		Consumption		Quantity		Price				Energy Swap				Deferred Tax
			Period				Per				Asset/(Liability)				Asset/(Liability)
							Unit				as of				as of
											December 31,				December 31,
											2013				2013
	Diesel - NYMEX Heating Oil Swap		Oct. – Nov., 2013		998,700 Gallons		$	2.88			$	132			$	(46	)
	Natural Gas - NYMEX Natural Gas Swap		Apr. – Oct., 2014		307,374 MMBTUs		$	3.67				143				(50	)
											$	275			$	(96	)
	As of September 30, 2014, Omega Protein has recorded a long-term liability of $0.2 million net of the current portion included in other current liabilities of $0.2 million to recognize the fair value of energy swap derivatives, and has also recorded a deferred tax asset of $0.1 million associated therewith. As of December 31, 2013, Omega Protein has recorded a current asset in prepaid expenses of $0.3 to recognize the fair value of energy swap derivatives, and has also recorded a deferred tax liability of $0.1 million associated therewith. The effective portion of the change in fair value from inception to September 30, 2014 is recorded in “accumulated other comprehensive loss” in the Company’s consolidated financial statements. The following table illustrates the changes recorded, net of tax, in accumulated other comprehensive loss resulting from the energy swap agreements (in thousands).
			Three Months Ended								Nine Months Ended
			September 30,								September 30,
			2014				2013				2014				2013
	Beginning balance		$	142			$	(78	)		$	179			$	28
	Net (gain) loss, net of tax, reclassified to unallocated inventory cost pool			27				(92	)			(62	)			(108	)
	Net change associated with current period swap transactions, net of tax			(406	)			193				(354	)			103
	Ending balance		$	(237	)		$	23			$	(237	)		$	23
	The $0.2 million reported in accumulated other comprehensive loss as of September 30, 2014 will be reclassified to inventory in the period when the energy consumption takes place. The amount to be reclassified, net of taxes, during the next 12 months is expected to be approximately $0.1 million.
	The aggregate fair value of derivative instruments in gross asset positions as of September 30, 2014 and December 31, 2013 was $11,000 and $0.3 million. These amounts represent the maximum exposure to loss at the reporting date as a result of all of the counterparties failing to perform as contracted. This exposure could be reduced by up to $0.4 million and $0, respectively, of liabilities included in master netting arrangements with those same counterparties.
	As of September 30, 2014 (in thousands)		Gross				Gross				Net Amounts
			Amounts of				Amounts of				of Assets
			Recognized				Assets				(Liabilities)
			Assets				(Liabilities)				Presented in
			(Liabilities)				Offset				the Balance
											Sheet
	Energy swap derivatives – liability position		$	11			$	(375	)		$	(364	)
	As of December 31, 2013 (in thousands)		Gross				Gross				Net Amounts
			Amounts of				Amounts of				of Assets
Recognized			Assets				(Liabilities)
Assets			(Liabilities)				Presented in
(Liabilities)			Offset				the Balance
							Sheet
Energy swap derivatives – asset position		$	275			$	-			$	275
If, at any time, the swaps are determined to be ineffective, in whole or in part, due to changes in the Company’s energy usage or underlying hedge agreements or assumptions, the fair value of the portion of the energy swaps determined to be ineffective will be recognized as a gain or loss in cost of sales for the applicable period. For the nine months ended September 30, 2013, the Company included an expense of $0.1 million in cost of sales resulting from transactions associated with the ineffectiveness of diesel energy swaps. See Note 17 – Fair Value Disclosures for additional information.
Plant Closure
Property, plant and equipment impairments related to the Cameron, Louisiana plant are made in accordance with the impairment of long-lived assets policy. Employee severance related charges have been recognized to the extent that the amount is probable, measurable and no-future service is expected or for those still employed, recognized pro-rata over the remaining service period. Ongoing clean-up and dismantlement costs will be recognized as incurred unless obligated and measureable by a contractual commitment. See Note 4 – Plant Closure for additional information related to the charges incurred.
Acquisitions, Goodwill and Other Intangible Assets
All of the Company’s goodwill and other intangible assets are the result of acquisitions in the human nutrition segment. This segment is comprised of three reporting units, 1) InCon and Cyvex collectively, 2) WSP and 3) Bioriginal. The Company has recorded goodwill and certain other identifiable intangible assets that are more fully explained in Note 3 – Acquisition of Wisconsin Specialty Protein, L.L.C., Note 2 – Acquisition of Bioriginal Food & Science Corp. and Note 10 – Goodwill and Other Intangible Assets.
Accumulated Other Comprehensive Loss
The components of accumulated other comprehensive (loss) gain, net of tax, included in stockholders’ equity are as follows:
Changes in Accumulated Other Comprehensive Loss by Component
For the Nine Months Ended September 30, 2014 (in thousands)
		Gains and Losses					Defined Benefit					Foreign currency				Total
		On Cash Flow					Pension Items					Translation
		Hedges										adjustment
Beginning balance December 31, 2013		$	179				$	(6,387	)			$	—			$	(6,208	)
Other comprehensive loss before reclassifications			(354	)				—					(449	)			(803	)
Amounts reclassified from accumulated other comprehensive loss			(62	)	(a)			446		(b)			—				384
Net current-period other comprehensive income			(416	)				446					(449	)			(419	)
Ending balance September 30, 2014		$	(237	)			$	(5,941	)			$	(449	)		$	(6,627	)
Changes in Accumulated Other Comprehensive Loss by Component
For the Nine Months Ended September 30, 2013 (in thousands)
		Gains and Losses					Defined Benefit					Total
		On Cash Flow					Pension Items
		Hedges
Beginning balance December 31, 2012		$	28				$	(9,952	)			$	(9,924	)
Other comprehensive loss before reclassifications			103					—					103
Amounts reclassified from accumulated other comprehensive loss			(108	)	(a)			753		(b)			645
Net current-period other comprehensive income			(5	)				753					748
Ending balance September 30, 2013		$	23				$	(9,199	)			$	(9,176	)
	(a)	This accumulated other comprehensive income component is reclassified to the unallocated inventory cost pool in the period when the energy consumption takes place.
	(b)	This accumulated other comprehensive income component is included in the computation of net periodic pension costs as amortization of actuarial loss which are explained in more detail in Note 16 to the consolidated financial statements in Item 8 of the Company’s Form 10-K for the fiscal year ended December 31, 2013.
Recently Issued Accounting Standards
In June 2014, the Financial Accounting Standards Board (the "FASB") issued Accounting Standards Update (ASU) No. 2014-12, Compensation — Stock Compensation (Topic 718), Accounting for Share-Based Payments When the Terms of an Award Provide That a Performance Target Could Be Achieved after the Requisite Service Period.  A performance target in a share-based payment that affects vesting and that could be achieved after the requisite service period should be accounted for as a performance condition under Accounting Standards Codification (ASC) 718, Compensation — Stock Compensation. As a result, the target is not reflected in the estimation of the award's grant date fair value. Compensation cost would be recognized over the required service period, if it is probable that the performance condition will be achieved.  The guidance is effective for annual periods beginning after December 15, 2015 and interim periods within those annual periods. Early adoption is permitted.  The Company does not expect this ASU to have a material impact on its Company’s consolidated results of operations, financial position and related disclosures.
In May 2014, the FASB issued Accounting Standards Update (“ASU”) 2014-09, Revenue from Contracts with Customers.  This ASU amends the existing accounting standards for revenue recognition and is based on the principle that revenue should be recognized to depict the transfer of goods or services to a customer at an amount that reflects the consideration a company expects to receive in exchange for those goods or services.  The Company is required to adopt this ASU on January 1, 2017.  The Company does not expect this ASU to have a material impact on its Company’s consolidated results of operations, financial position and related disclosures.
In April 2014, the FASB issued ASU No. 2014-08, Presentation of Financial Statements and Property, Plant and Equipment: Reporting Discontinued Operations and Disclosures of Disposals of Components of an Entity. This ASU changes the criteria for determining which disposals can be presented as discontinued operations and modifies related disclosure requirements. Under the new guidance, a discontinued operation is defined as a disposal of a component or group of components that is disposed of or is classified as held for sale and represents a strategic shift that has or will have a major effect on an entity's operations and financial results. The new standard is effective in annual periods beginning on or after December 15, 2014 with early adoption permitted. The guidance applies prospectively to new disposals and new classifications of disposal groups as held for sale after the effective date. The Company’s adoption of FASB ASU No. 2014-08 is not expected to impact on the Company’s consolidated results of operations, financial position and related disclosures.
In July 2013, the FASB issued ASU No. 2013-11, Income Taxes: Presentation of an Unrecognized Tax Benefit When a Net Operating Loss Carryforward, a Similar Tax Loss, or a Tax Credit Carryforward Exists. This ASU amended the Income Taxes Topic of the Accounting Standards Codification to eliminate a diversity in practice for the presentation of unrecognized tax benefits when net operating loss carryforwards, similar tax losses or tax credit carryforwards exist. The amendment requires that the unrecognized tax benefit be presented as a reduction of the deferred tax assets associated with the carryforwards except in certain circumstances when it would be reflected as a liability. This guidance is effective for annual periods and interim periods within those annual periods beginning after December 15, 2013. The Company’s adoption of FASB ASU No. 2013-11 effective January 1, 2014 did not have an impact on the Company’s consolidated results of operations, financial position and related disclosures.
Foreign Currency Translations
All amounts are expressed in U.S. dollars unless otherwise indicated. The U.S. dollar is the functional currency of Bioriginal’s Canadian-based subsidiaries (“Bioriginal Canada”). Monetary assets and liabilities denominated in foreign currencies are translated into U.S. dollars at exchange rates in effect at the balance sheet date. Non-monetary items are translated at rates of exchange in effect when the assets were acquired or obligations incurred. Revenue and expenses are translated at average rates in effect in the period of the transaction. Foreign exchange gains and losses are included in the unaudited condensed consolidated statement of comprehensive income.
The Euro is the functional currency of Bioriginal’s Netherlands-based subsidiaries (“Bioriginal Europe”). The operations of these subsidiaries are considered self-sustaining and their financial statements are translated into U.S. dollars using the current rate method. Under this method, all assets and liabilities are translated to U.S. dollars at exchange rates in effect at the balance sheet date and all revenue and expenses are translated at rates in effect at the time of the transactions. Exchange gains and losses arising from this translation, representing the net unrealized foreign currency translation gain (loss) on the Company's net investment in its self-sustaining subsidiaries, are recorded in the accumulated other comprehensive income (loss) component of shareholders' equity. Adjustments to the accumulated other comprehensive income (loss) account are not recorded in the unaudited condensed consolidated statement of comprehensive income until realized through a reduction in the Company's net investment in such operations.
Stock-Based Compensation
Stock Options
The Company has a stock-based compensation plan, which is described in more detail in Note 16 to the consolidated financial statements in Item 8 of the Company’s Form 10-K for the fiscal year ended December 31, 2013. The Company has issued non-qualified stock options under its stock incentive plans. The options generally vested in equal installments over three years and expire in ten years.
Net income for the three months ended September 30, 2013 includes $0.2 million ($0.1 million after-tax), respectively, of stock-based compensation costs related to stock options. Net income for the nine months ended September 30, 2013 includes $0.5 million ($0.3 million after-tax), respectively, of stock-based compensation costs related to stock options. The stock-based compensation costs related to stock options are recorded primarily in selling, general and administrative expenses in the unaudited condensed consolidated statement of comprehensive income. As of September 30, 2014 there was $0 of unrecognized compensation costs related to non-vested stock options that is expected to be recognized during the remainder of fiscal year 2014.
Restricted Stock
The Company has issued shares of restricted stock under the 2006 Incentive Plan. Shares of restricted stock generally vest on the third anniversary of the grant date or in equal installments over three years except for shares of restricted stock granted to non-employee directors which vest six months after the grant date. Non-vested shares are generally forfeited upon the termination of employment or service as a director. Holders of shares of restricted stock are entitled to all rights of a stockholder of the Company, including the right to vote the shares and receive any dividends or other distributions. The non-vested shares are considered participating securities and the Company has calculated earnings per share using the two-class method. See Note 14 – Reconciliation of Basic and Diluted Per Share Data.
During the nine month periods ended September 30, 2014 and 2013, the Company issued 356,262 and 58,036 shares of restricted stock, respectively, under the 2006 Incentive Plan to employees and non-employee directors. The Company’s compensation expense related to restricted stock, which is primarily reflected in selling, general and administrative expenses in the unaudited condensed consolidated statement of comprehensive income, was approximately $0.6 million and $0.4 million ($0.4 million and $0.3 million after tax) for the three months ended September 30, 2014 and 2013, respectively. The Company’s compensation expense related to restricted stock was approximately $1.3 million and $1.0 million ($0.9 million and $0.6 million after tax) for the nine months ended September 30, 2014 and 2013, respectively. As of September 30, 2014, there was approximately $5.0 million ($3.2 million after tax) of unrecognized compensation expense related to non-vested restricted stock that is expected to be recognized over a weighted-average period of 1.4 years, of which $0.7 million ($0.5 million after-tax) of compensation expense is expected to be recognized during the remainder of fiscal year 2014.
Performance Units
On February 6, 2014, the Company adopted a cash incentive performance unit plan. The value of the units will be determined by reference to the performance of the Company’s common stock during the relevant performance period compared to the performance of the Russell 2000 Index member companies (the “Peer Group”) during that same period. One third of the Performance Units granted will be earned at the end of each calendar year of the performance period and will be valued for the calendar year based on the Total Shareholder Return (“TSR”) of the Company compared to the TSR of the Peer Group. The performance units contain a service provision of approximately 3 years and are liability-classified awards included in other long-term liabilities which are adjusted to fair value on a quarterly basis.
The Company’s compensation expense related to performance units was approximately $0.1 million and $0.4 million for the three and nine months ended September 30, 2014, respectively, which is primarily reflected in selling, general and administrative expenses in the unaudited condensed consolidated statement of comprehensive income. As of September 30, 2014, there was approximately $1.2 million of unrecognized compensation cost related to performance units that is expected to be recognized over the next 2.25 years, of which $0.1 million of compensation expense is expected to be recognized during the remainder of fiscal year 2014.

Note_2_Acquisition_of_Biorigin

Note 2 - Acquisition of Bioriginal Food & Science Corp.	9 Months Ended
	Sep. 30, 2014
Bioriginal [Member]	'
Note 2 - Acquisition of Bioriginal Food & Science Corp. [Line Items]	'
Mergers, Acquisitions and Dispositions Disclosures [Text Block]	'
	NOTE 2. ACQUISITION OF BIORIGINAL FOOD & SCIENCE CORP.
	A. Description of the Transaction
	On September 5, 2014, the Company acquired all of the issued and outstanding equity of Bioriginal in a stock purchase pursuant to the terms of a Share Purchase Agreement (“Purchase Agreement”). Bioriginal is now a wholly owned subsidiary of the Company.  Bioriginal is a leading supplier of plant and marine based specialty oils and essential fatty acids to the food and nutraceutical industries across North America, Europe and Asia. Bioriginal is included as part of the Company’s human nutrition segment.
	B. Recording of Assets Acquired and Liabilities Assumed
	In connection with its acquisition of Bioriginal, the Company paid an aggregate purchase price of $70.5 million, plus an estimated working capital adjustment of $0.7 million, to the sellers as follows: (i) $46.5 million in cash to the sellers, (ii) assumption of approximately $21.5 million of Bioriginal’s indebtedness, and (iii) issuance of 238,377 shares of restricted common stock of the Company valued at approximately $3.2 million (based on a 30-day average closing price) to certain sellers (the “Management Sellers”). The restrictions on the shares will terminate, with certain exceptions, on the third anniversary of the closing date and are subject to the terms and conditions of the Purchase Agreement; see Note - 1 Significant Accounting Policies Summary of Operations and Basis of Presentation for more information on Restricted Stock. The Purchase Agreement also provides for a performance-based earn-out amount of up to a maximum of $8.8 million Canadian dollars to be paid in September 2017 to the Management Sellers for achieving or exceeding certain adjusted EBITDA targets for Bioriginal during calendar years 2014 through 2016; see Note 13 Commitments and Contingencies for additional information.
	The Company incurred approximately $2.7 million in pretax transaction costs directly related to the acquisition that were expensed and included in selling, general and administrative expenses in the consolidated statement of comprehensive income for the nine months ended September 30, 2014. The acquisition costs consisted primarily of legal, advisory, valuation, and other consulting fees. The transaction has been accounted for using the acquisition method of accounting which requires, among other things, that all assets acquired and liabilities assumed from acquisitions be recognized at their fair values as of the acquisition date. Any excess of the purchase price over the fair values of the net assets acquired are recorded as goodwill. The following table shows the preliminary allocation of the purchase price:
			(in thousands)
	Cash		$	93
	Accounts receivable, net			15,072
	Inventories			20,309
	Other current assets, net including prepaid expenses			1,820
	Property, plant, and equipment, net			3,026
	Identifiable intangible assets (a)			14,136
	Liabilities assumed			(39,249	)
	Total identifiable net assets			15,207
	Goodwill			31,274
	Total consideration		$	46,481
		(a)	See Note 10 – Goodwill and Other Intangible Assets for weighted average lives.
	Goodwill is calculated as the excess of the consideration transferred over the net assets recognized and represents the future economic benefits arising from other assets acquired that could not be individually identified and separately recognized. Specifically, the goodwill recorded as part of the acquisition of Bioriginal includes the following:
	● the expected synergies and other benefits that the Company believes may result from combining the operations of Bioriginal with the operations of the Company’s human nutrition segment,
	● any intangible assets that do not qualify for separate recognition, and
	● the value of the going-concern element of Bioriginal’s existing business (the higher rate of return on the assembled collection of net assets versus if the Company had acquired all of the net assets separately).
	The Company does not amortize goodwill or indefinite-lived intangible assets but performs tests for impairment annually, or when indications of potential impairment exist, utilizing a fair value approach at the reporting unit level. See Note 10 - Goodwill and Other Intangible Assets, for more information about goodwill and other intangible assets.
	C. Unaudited Pro Forma Financial Information
	The unaudited financial information in the table below summarizes the combined results of operations of the Company and Biorginial on a pro forma basis, as though the companies had been combined as of January 1, 2013. The pro forma financial information is presented for informational purposes only and is not indicative of the results of operations that would have been achieved if the acquisition had actually taken place on January 1, 2013 and is not intended to be a projection of future results or trends.
			Revenue			Net income (loss)
			(in thousands)
	Bioriginal from September 5, 2014 – September 30, 2014		$	7,723		$	(281	)
	2014 supplemental pro forma from July 1, 2014 – September 30, 2014		$	91,842		$	1,055
	2014 supplemental pro forma from January 1, 2014 – September 30, 2014		$	289,174		$	17,582
	2013 supplemental pro forma from July 1, 2013 – September 30, 2013		$	113,519		$	14,825
	2013 supplemental pro forma from January 1, 2013 – September 30, 2013		$	259,509		$	23,674
Wisconsin Specialty Protein [Member]	'
Note 2 - Acquisition of Bioriginal Food & Science Corp. [Line Items]	'
Mergers, Acquisitions and Dispositions Disclosures [Text Block]	'
	NOTE 3. ACQUISITION OF WISCONSIN SPECIALTY PROTEIN, L.L.C.
	A. Description of the Transaction
	In February 2013, the Company acquired 100% of the outstanding equity interest of WSP, a Wisconsin limited liability company, in a cash transaction pursuant to the terms of an agreement and plan of merger. WSP is now a wholly owned subsidiary of the Company. WSP produces a variety of value-added whey protein ingredients for the food and nutritional supplement industries, including organic and other specialty protein products, using processes applicable to a variety of nutritional dairy ingredients. WSP is included as part of the Company’s human nutrition segment.
	B. Recording of Assets Acquired and Liabilities Assumed
	The Company paid an aggregate cash purchase price for the equity of WSP of $26.5 million plus $0.6 million representing WSP’s excess working capital on the closing date and reimbursable capital expenditures, utilizing cash on hand.
	The Company incurred approximately $0.8 million in pretax transaction costs directly related to the acquisition that were expensed and included in selling, general and administrative expenses in the consolidated statement of comprehensive income for the year ended December 31, 2013. The acquisition costs consisted primarily of legal, advisory, valuation, and other consulting fees. The transaction has been accounted for using the acquisition method of accounting which requires, among other things, that all assets acquired and liabilities assumed from acquisitions be recognized at their fair values as of the acquisition date. Any excess of the purchase price over the fair values of the net assets acquired are recorded as goodwill. The following table shows the allocation of the purchase price.
			(in thousands)
	Cash		$	403
	Other current assets, net including receivables, prepaid and inventory			2,515
	Property, plant, and equipment, net			14,095
	Identifiable intangible assets (a)			4,448
	Liabilities assumed			(5,996	)
	Total identifiable net assets			15,465
	Goodwill			11,614
	Total consideration		$	27,079
		(b)	See Note 10 – Goodwill and Other Intangible Assets for weighted average lives.
	Goodwill is calculated as the excess of the consideration transferred over the net assets recognized and represents the future economic benefits arising from other assets acquired that could not be individually identified and separately recognized. Specifically, the goodwill recorded as part of the acquisition of WSP includes the following:
	● the expected synergies and other benefits that the Company believes may result from combining the operations of WSP with the operations of the Company’s human nutrition segment,
	● any intangible assets that do not qualify for separate recognition, and
	● the value of the going-concern element of WSP’s existing business (the higher rate of return on the assembled collection of net assets versus if the Company had acquired all of the net assets separately).
	The Company does not amortize goodwill or indefinite-lived intangible assets but performs tests for impairment annually, or when indications of potential impairment exist, utilizing a fair value approach at the reporting unit level. See Note 10 - Goodwill and Other Intangible Assets, for more information about goodwill and other intangible assets.
	C. Unaudited Pro Forma Financial Information
	The unaudited financial information in the table below summarizes the combined results of operations of the Company and WSP on a pro forma basis, as though the companies had been combined as of January 1, 2013. The pro forma financial information is presented for informational purposes only and is not indicative of the results of operations that would have been achieved if the acquisition had actually taken place on January 1, 2013 and is not intended to be a projection of future results or trends.
			Revenue			Net income (loss)
			(in thousands)
	WSP from February 27, 2013 – September 30, 2013		$	6,603		$	(35	)
	2013 supplemental pro forma from January 1, 2013 – September 30, 2013		$	180,388		$	20,800

Note_4_Plant_Closure

Note 4 - Plant Closure	9 Months Ended
	Sep. 30, 2014
Disposal Groups Plant Closure Disclsoure [Abstract]	'
Disposal Groups Plant Closure Disclsoure [Text Block]	'
	NOTE 4. PLANT CLOSURE
	In December 2013, the Company effectively closed its menhaden fish processing plant located in Cameron, Louisiana and re-deployed certain vessels from that facility to the Company’s other Gulf Coast facilities located in Abbeville, Louisiana and Moss Point, Mississippi. In conjunction with the closure, the following charges were incurred in the Company’s consolidated statements of comprehensive income for the three and nine months ended September 30, 2014 and cumulative to date:
		Three Months		Nine Months		Cumulative to
		Ended		Ended		Date
		September 30,		September 30,
		2014		2014
		(in thousands)
	Impairment and relocation of property, plant and equipment	$	675	$	2,414	$	7,210
	Write-off material and supplies inventory		26		43		140
	Employee severance costs		100		340		685
	Estimated decommissioning costs		—		—		250
	Other ongoing closure costs not attributable to future production		742		2,685		3,794
	Total loss related to plant closure	$	1,543	$	5,482	$	12,079
	In addition to the above recognized losses, the Company expects that it may have additional losses related to additional impairment and relocation of property, plant and equipment, ongoing employee severance expenses and ongoing costs not attributable to future production such as clean-up and disassembly.

Note_5_Receivables_Net

Note 5 - Receivables, Net	9 Months Ended
	Sep. 30, 2014
Receivables [Abstract]	'
Loans, Notes, Trade and Other Receivables Disclosure [Text Block]	'
	NOTE 5. RECEIVABLES, NET
	Receivables as of September 30, 2014 and December 31, 2013 are summarized as follows:
		September			December 31,
		30, 2014			2013
		(in thousands)
	Trade	$	44,282		$	18,689
	Insurance		1,728			1,806
	Income tax		1,259			714
	Other		135			310
	Total accounts receivable		47,404			21,519
	Less allowance for doubtful accounts		(1,305	)		(379	)
	Receivables, net	$	46,099		$	21,140

Note_6_Inventory

Note 6 - Inventory	9 Months Ended
	Sep. 30, 2014
Inventory Disclosure [Abstract]	'
Inventory Disclosure [Text Block]	'
	NOTE 6. INVENTORY
	The major classes of inventory as of September 30, 2014, December 31, 2013 and September 30, 2013 are summarized as follows:
		September 30,		December 31,		September 30,
		2014		2013		2013
		(in thousands)
	Fish meal	$	46,544	$	30,119	$	35,130
	Fish oil		25,458		41,081		40,186
	Fish solubles		708		2,599		2,777
	Nutraceutical products		4,141		3,650		4,563
	Bioriginal products		19,089		—		—
	Dairy protein products		2,072		1,355		1,484
	Unallocated inventory cost pool (including off-season costs)		242		6,655		(4,062	)
	Other materials and supplies		9,665		8,880		10,203
	Total inventory	$	107,919	$	94,339	$	90,281
	Inventory at September 30, 2014, December 31, 2013 and September 30, 2013 is stated at the lower of cost or market. The elements of September 30, 2014 unallocated inventory cost pool include Omega Protein’s plant and vessel related labor, utilities, rent, repairs and depreciation, which are allocated to inventories produced through the 2014 fishing season.

Note_7_Prepaid_Expenses_and_Ot

Note 7 - Prepaid Expenses and Other Current Assets	9 Months Ended
	Sep. 30, 2014
Disclosure Text Block Supplement [Abstract]	'
Other Current Assets [Text Block]	'
	NOTE 7. PREPAID EXPENSES AND OTHER CURRENT ASSETS
	Prepaid expenses and other current assets as of September 30, 2014 and December 31, 2013 are summarized below:
		September 30,		December 31,
		2014		2013
		(in thousands)
	Prepaid insurance	$	2,749	$	2,422
	Selling expenses		1,236		869
	Fair market value of energy swaps, current portion		11		275
	Whey process filters		98		38
	Leases		228		53
	Other prepaids and expenses		1,589		258
	Total prepaid expenses and other current assets	$	5,911	$	3,915
	Amounts included in prepaid expenses and other current assets consist primarily of prepaid operating expenses including insurance, rents, and selling expenses. Energy swap assets are valued at each reporting date at their fair value (see Note 17 – Fair Value Disclosures for additional information). Prepaid selling expenses are expensed in those periods in which the related revenue is recognized.

Note_8_Other_Assets

Note 8 - Other Assets	9 Months Ended
	Sep. 30, 2014
Disclosure Text Block Supplement [Abstract]	'
Other Assets Disclosure [Text Block]	'
	NOTE 8. OTHER ASSETS
	Other assets as of September 30, 2014 and December 31, 2013 are summarized as follows:
		September 30,		December 31,
		2014		2013
		(in thousands)
	Fish nets, net of accumulated amortization of $2,377 and $2,610	$	1,420	$	1,517
	Insurance receivable		424		3,048
	Title XI debt issuance costs		249		272
	Other debt issuance costs		283		299
	Deposits and other		290		98
	Total other assets, net	$	2,666	$	5,234
	Amortization expense for fishing nets amounted to approximately $0.3 million and $0.4 million for the three months ended September 30, 2014 and 2013 and $1.0 million for the nine months ended September 30, 2014 and 2013.
	As of September 30, 2014 and December 31, 2013, insurance receivables primarily relates to Jones Act claims for employees aboard its vessels. This estimated amount is recorded gross of estimated claims which may be due to claimants and is included in accrued insurance liabilities.
	The Company carries insurance for certain losses relating to its fishing vessels and Jones Act liability for employees aboard its vessels (collectively, “Vessel Claims Insurance”). The typical Vessel Claims Insurance policy contains an annual aggregate deductible (“AAD”) for which Omega Protein remains responsible, while the insurance carrier is responsible for all applicable amounts which exceed the AAD. It is Omega Protein’s policy to accrue current amounts due and record amounts paid out on each claim. Once payments exceed the AAD, Omega Protein records an insurance receivable for a given policy year.

Note_9_Property_Plant_and_Equi

Note 9 - Property, Plant, and Equipment	9 Months Ended
	Sep. 30, 2014
Property, Plant and Equipment [Abstract]	'
Property, Plant and Equipment Disclosure [Text Block]	'
	NOTE 9. PROPERTY, PLANT AND EQUIPMENT
	Property, plant and equipment as of September 30, 2014 and December 31, 2013 are summarized as follows:
		September 30,			December 31,
		2014			2013
		(in thousands)
	Land	$	9,087		$	7,457
	Plant assets		185,986			159,337
	Fishing vessels		111,675			101,745
	Furniture and fixtures		7,655			7,091
	Construction in progress		14,609			16,846
	Total property and equipment		329,012			292,476
	Less accumulated depreciation and impairment		(163,483	)		(148,363	)
	Property, plant and equipment, net	$	165,529		$	144,113
	Depreciation expense for the three months ended September 30, 2014 and 2013 was $5.1 million and $4.8 million, respectively, and $14.4 million and $14.1 million for the nine months ended September 30, 2014 and 2013, respectively.
	The Company capitalizes interest as part of the acquisition cost of a qualifying asset. Interest is capitalized only during the period of time required to complete and prepare the asset for its intended use. For the three months ended September 30, 2014 and 2013, the Company capitalized interest of approximately $0.1 million. For the nine months ended September 30, 2014 and 2013, the Company capitalized interest of approximately $0.5 million and $0.2 million, respectively.
	In December 2013, the Company closed its Cameron, Louisiana menhaden processing plant and re-deployed some of its harvesting and processing assets to the three remaining menhaden processing plants. As a result of the closure, the Company recognized a cumulative $7.2 million in impairment of its fixed assets that it does not plan to use in future operations. For more information see Note 4 – Plant Closure.

Note_10_Goodwill_and_Other_Int

Note 10 - Goodwill and Other Intangible Assets	9 Months Ended
	Sep. 30, 2014
Goodwill and Intangible Assets Disclosure [Abstract]	'
Goodwill and Intangible Assets Disclosure [Text Block]	'
	NOTE 10. GOODWILL AND OTHER INTANGIBLE ASSETS
	Goodwill is measured as the excess of the cost of an acquisition over the sum of the amounts assigned to the fair value of tangible and intangible assets acquired less liabilities assumed.  All of the Company’s goodwill and other intangible assets are the result of acquisitions in the human nutrition segment.
	Goodwill is tested annually for impairment of value, and whenever an event occurs or circumstances change that would more likely than not indicate the carrying amount of the asset is impaired. Determining whether an indicator of impairment has occurred during an interim period involves a significant amount of judgment.  During the interim periods, qualitative factors such as deterioration in general economic conditions, changes in the market for an entity’s products or services, declines in actual or planned revenue or earnings compared with actual and projected results of relevant prior periods, among others, are evaluated to determine if a triggering event which would result in a potential impairment has incurred.
	As of the December 31, 2013, the results of the annual quantitative tests did not result in any impairment of goodwill because the fair values of each of the reporting units exceeded their respective carrying values. Specifically, our two reporting units, InCon/Cyvex and WSP, each had calculated fair values that were 21% in excess of their carrying values.  Additionally, the calculated fair value of InCon’s trade secrets exceeded its carrying value by 5%.  Key assumptions in the fair value calculations include discount rates and future sales volumes, prices and production costs.  It should be noted that these assumptions require speculation and are highly subjective given the early stage and transitional nature of the businesses, and the use of other reasonable, but different, assumptions could produce significantly different fair values and, potentially, impairments.
	Our annual quantitative tests have assumed increasing cash flows over the next several years, based on anticipated sales growth and improved profitability; through the nine months ended September 30, 2014, the two reporting units have not achieved the assumed results.  If future cash flow expectations decline sufficiently, the estimated fair values would be reduced and could potentially result in a material impairment in a subsequent period.
	The following table summarizes the changes in the carrying amount of goodwill resulting from the Company’s acquisitions of Biorginal, WSP, Cyvex and InCon (in thousands):
		Bioriginal			WSP			Cyvex and		Total
								Incon
	1-Jan-14	$	—			11,614			7,986	$	19,600
	Acquisitions		31,274			—			—		31,274
	Foreign currency translation adjustment		(216	)		—			—		(216	)
	30-Sep-14	$	31,058			11,614			7,986	$	50,658
	The following table summarizes the Company’s intangible assets (dollars in thousands):
		September 30,			December 31,			Weighted
		2014			2013			Average
								Life (years)
	Carrying value of intangible assets subject to amortization:
	Customer relationships and non-competes	$	16,161		$	5,930
	Less accumulated amortization		(1,199	)		(613	)		10
	Total intangible assets subject to amortization, net	$	14,962		$	5,317
	Indefinite life intangible assets – trade names/secrets and other		6,426			2,615
	Total intangible assets	$	21,388		$	7,932
	Amortization expense of the Company’s intangible assets for the three months ended September 30, 2014 and 2013 was approximately $0.3 million and for the nine months ended September 30, 2014 and 2013 was approximately $0.6 million. Estimated future amortization expense related to intangible assets is as follows (in thousands):
	Remainder of 2014	$	419
	2015		1,669
	2016		1,669
	2017		1,669
	Thereafter		9,536
	Total estimated future amortization expense	$	14,962
	The Company’s goodwill and other intangible assets are more fully explained in Note 11 to the consolidated financial statements in Item 8 of the Company’s Form 10-K for the fiscal year ended December 31, 2013.

Note_11_Notes_Payable_and_Long

Note 11 - Notes Payable and Long-Term Debt	9 Months Ended
	Sep. 30, 2014
Disclosure Text Block [Abstract]	'
Long-term Debt [Text Block]	'
	NOTE 11. NOTES PAYABLE AND LONG-TERM DEBT
	At September 30, 2014 and December 31, 2013, the Company's long-term debt consisted of the following:
			September 30,			December 31,
			2014			2013
			(in thousands)
	U.S. government guaranteed obligations (Title XI loans) collateralized by a first lien on certain vessels and certain plant assets:
	Amounts due in installments through 2025, interest from 5.7% to 7.0%		$	21,761		$	24,211
	Amounts due in installments through 2014, interest at Eurodollar rates plus 0.5% (0.7% at December 31, 2013)			—			31
	Amounts due on Loan Agreement in March 2017, interest at LIBOR plus an applicable rate (1.74% to 1.84% at September 30, 2014)			17,000			—
	ING credit facility, interest at EURIBOR plus an applicable rate (2.98% at September 30, 2014)			—			—
	ING Commercial Finance B.V., interest at EURIBOR plus an applicable rate (1.76% at September 30, 2014)			2,214			—
	HSBC credit facility, matures March 2019, interest at HSBC prime rate plus an applicable rate (4.5% at September 30, 2014)			7,558			—
	HSBC demand loan, amounts due in installments through March 2019, interest at HSBC’s Prime rate plus an applicable rate (currently 6.75%)			6,394			—
	Total debt			54,927			24,242
	Less current maturities			(14,157	)		(3,112	)
	Long-term debt		$	40,770		$	21,130
	The Title XI loans are secured by certain liens on the Company’s fishing vessels and mortgages on the Company’s Reedville, Virginia and Abbeville, Louisiana plants.
	In June 2011, pursuant to the Title XI program, the United States Department of Commerce Fisheries Finance Program (the “FFP”) approved a financing application made by the Company in the amount of $10.0 million (the “Approval Letter”) which expires on June 20, 2016. To date, the Company has not borrowed any amounts under the Approval Letter and its ability to do so has been adversely affected by an EPA notice that the Company’s Omega Protein subsidiary is ineligible, as a result of its previous convictions under the Clean Water Act, for receipt of government contracts or benefits in certain cases. See “Risk Factors - If our Omega Protein subsidiary fails to comply with the terms of its probation under a plea agreement entered into in June 2013, we could be subject to criminal prosecution” in the Company’s Form 10-K for the year ended December 31, 2013 for further detail on this EPA notice. As of September 30, 2014, the Company had approximately $21.8 million of borrowings outstanding under Title XI and was in compliance with all of the covenants contained therein.
	In March 2012, the Company entered into an Amended and Restated Loan Agreement (the “Loan Agreement”) with Wells Fargo Bank, National Association, as administrative agent (the “Agent”) for the lenders (currently Wells Fargo Bank, National Association and JP Morgan Chase Bank, N.A.) (collectively, the “Lenders”) pursuant to which the Lenders agreed to extend credit to the Company in the form of loans (each a “Loan” and collectively, the “Loans”) on a revolving basis of up to $60.0 million (the “Commitment”). In September 2014, the Company and the Lenders amended the Loan Agreement to (i) permit the acquisition by the Company of Bioriginal, (ii) permit certain existing indebtedness of Bioriginal and the related liens, (iii) add certain collateral under the Loan Agreement relating to Bioriginal, and (iv) increase the commitment of the Lenders under the Loan Agreement by $10 million to a total of $70 million. The Loan Agreement also requires the Company to comply with various affirmative and negative covenants affecting the Company’s businesses and operations, including various financial covenants.
	All Loans and all other obligations outstanding under the Loan Agreement are payable in full on March 21, 2017. As of September 30, 2014 and December 31, 2013, the Company had $17.0 million and $0, respectively, outstanding under the Loan Agreement and approximately $3.5 million in letters of credit. As of September 30, 2014, the Company was in compliance with all financial covenants under the Loan Agreement. The Company has no off-balance sheet arrangements other than normal operating leases and standby letters of credit.
	The Company’s notes payable and long-term debt are more fully explained in Note 12 to the consolidated financial statements in Item 8 of the Company’s Form 10-K for the fiscal year ended December 31, 2013 and the Company’s Current Report on Form 8-K dated September 5, 2014.
	On June 6, 2010, Bioriginal Europe entered into a credit facility with ING Bank N.V. which provides borrowings up to 250,000 Euro.  Under the credit facility, interest is paid at 2.97% plus the EURIBOR rate (currently 2.98%) and is secured by Bioriginal Europe’s equipment and a loan to Bioriginal Canada.  The credit facility contains cross default provisions and other covenants.   As of September 30, 2014, $0 was outstanding under this credit facility.
	On March 31, 2012, Bioriginal Europe entered into a credit facility with ING Commercial Finance B.V. which provides borrowings up to an amount based on accounts receivable and inventory balances, and matures on March 31, 2015.  Advances are repayable on demand and bear interest payable monthly at 1.75% + EURIBOR (currently 1.76%).  The credit facility is secured by accounts receivable and inventory of Bioriginal Europe to a maximum of 85% of accounts receivable and 60% of inventory.   The credit facility contains cross default provisions and other covenants.  As of September 30, 2014, $2.2 million was outstanding under this credit facility.
	On April 15, 2014, Bioriginal Canada entered into a credit facility with HSBC Bank of Canada (the “Bioriginal Credit Facility”) which provides borrowings up to $20,000,000 Canadian dollars and matures on March 15, 2019, subject to HSBC’s right to terminate the facility in its sole discretion. Under the Bioriginal Credit Facility, Bioriginal Canada has an operating line of credit for which interest is paid at HSBC prime rate plus 1.25% (currently 4.5%) and is secured by Bioriginal Canada’s accounts receivable and inventory to a maximum of $17,000,000 Canadian dollars and is payable on demand. Additionally, there is a separate maximum of $4,200,000 related to letters of credit which pays interest at the same rate as the operating line of credit. At September 30, 2014 Bioriginal has issued $4,200,000 in letters of credit in support of product purchases from a foreign supplier. Generally these letters of credit are insured by Export Development Canada and are not considered to be drawn under this credit facility. As of September 30, 2014, $7.6 million was outstanding under these subsections of the credit facility.
	Also within the Bioriginal Credit Facility is a cash flow loan which is repayable in monthly installments of $166,700 Canadian dollars plus interest at a rate between HSBC's Prime rate plus 2.25% to 4.25% depending on a quarterly covenant calculation of Funded Debt to EBITDA (currently 6.75%) and is secured by a General Security Agreement. As of September 30, 2014, $6.4 million was outstanding under this subsection of the credit facility.
	The Bioriginal Credit Facility requires Bioriginal to comply with various affirmative and negative covenants affecting Bioriginal’s businesses and operations. In addition, the Bioriginal Credit Facility requires Bioriginal to comply with the following financial covenants:
		●	Bioriginal may not permit its ratio of Funded Debt to EBITDA to at any time exceed 3.0 to 1;
		●	Bioriginal may not permit its Current Ratio at any time to be less than 1.30 to 1;
		●	Bioriginal may not permit its ratio of Debt Service Coverage to be less than 1.25 to 1 to be tested only at each year end based on audited financial statements of Bioriginal;
		●	Bioriginal may not make capital expenditures aggregating in any one year in excess of $500,000 Canadian dollars, which amount shall not be cumulative from year to year;
		●	Bioriginal may not declare or pay any dividends if the Funded Debt EBITDA is greater than 2.0 to 1

Note_12_Accrued_Liabilities

Note 12 - Accrued Liabilities	9 Months Ended
	Sep. 30, 2014
Disclosure Text Block Supplement [Abstract]	'
Accounts Payable, Accrued Liabilities, and Other Liabilities Disclosure, Current [Text Block]	'
	NOTE 12. ACCRUED LIABILITIES
	Accrued liabilities as of September 30, 2014 and December 31, 2013 are summarized as follows:
		September 30,		December 31,
		2014		2013
		(in thousands)
	Insurance	$	5,689	$	7,222
	Reserve for plant closure costs		542		595
	Salary and benefits		14,392		9,423
	Trade creditors		6,136		5,100
	Taxes, other than income tax		1,480		64
	Income tax		2,819		4,132
	Deferred revenue		6,929		2,362
	Accrued interest		201		200
	Other		260		47
	Total accrued liabilities	$	38,448	$	29,145
	As of September 30, 2014 and December 31, 2013, deferred revenue represents payments primarily received from international customers related to revenues which were not recognized until the subsequent period due to revenue recognition criteria.

Note_13_Commitments_and_Contin

Note 13 - Commitments and Contingencies	9 Months Ended
	Sep. 30, 2014
Commitments and Contingencies Disclosure [Abstract]	'
Commitments and Contingencies Disclosure [Text Block]	'
	NOTE 13. COMMITMENTS AND CONTINGENCIES
	Bioriginal Contingency
	In September 2014, the Company acquired all of the outstanding equity of Bioriginal pursuant to the terms of a share purchase agreement. A portion of the equity of Bioriginal was indirectly held by the Management Sellers, who continue to be employed by Bioriginal and share in the management of Bioriginal’s business. Bioriginal is now a wholly owned subsidiary of the Company.
	In addition to the acquisition date cash purchase price and restricted stock, the Management Sellers may also earn additional amounts based on the annual adjusted EBITDA of Bioriginal’s business during each of the calendar years 2014 through 2016. If the adjusted EBITDA meets or exceeds agreed upon targets for the calendar year, the payout ranging from $1.7 million Canadian dollars to $2.9 million Canadian dollars will be earned, subject to certain forfeitures based on termination of Management Sellers’ employment. The maximum total payment for all three years is $8.8 million Canadian dollars.
	The earn-out payments in Canadian dollars, if any, will be estimated on a quarterly basis and paid in September 2017. The Company will record the estimated contractual obligation as compensation expense during each year as it is deemed probable that such amount will be payable. For the nine months ended September 30, 2014, the Company recorded a $0.1 million liability related to this provision of the agreement.
	InCon Contingency
	In September 2011, the Company acquired all of the outstanding equity of InCon in a cash transaction pursuant to the terms of an equity purchase agreement. The equity of InCon was indirectly held by four individuals (the “Sellers”), some of whom continue to be employed by InCon and share in the management of InCon’s business. InCon is now a wholly owned subsidiary of the Company.
	In addition to the acquisition date cash purchase price, the Sellers may also earn additional amounts based on the annual EBITDA of InCon’s toll processing and specialty product business during calendar years 2012 through 2016. The Company and the Sellers amended the earn-out terms on April 25, 2013 by lowering the earn-out by 35% of the original formula in 2013 and all future years. The annual earn-out provisions (as amended) are determined based on a percentage of InCon’s EBITDA, adjusted for certain product sales and costs, which percentage ranges from 3.25% of the first $3.0 million of EBITDA to 19.5% of EBITDA in excess of $12.0 million.
	The annual earn-out payments, if any, will be estimated on a quarterly basis and paid subsequent to year end. The Company will record the estimated contractual obligation as compensation expense during each year as it is deemed probable that such amount will be payable. In addition, the earn-out payments are subject to certain reductions associated with future InCon capital expenditures and forfeitures based on termination of employment of a Seller. For the nine months ended September 30, 2014 and year ended December 31, 2013, the Company has not recorded an annual earn-out estimate.
	Legal Contingencies
	The Company was named in a lawsuit filed in federal court in the Southern District of Mississippi in connection with the death of an employee at the Company’s Moss Point, Mississippi plant in April 2012. The lawsuit alleges that the Company intentionally caused the employee’s death, a claim that the Company emphatically denies. The Company believes that the claim is covered by the state’s workers compensation statute which provides that worker compensation benefits are the exclusive remedy for a work-related injury or death under these circumstances. The Company filed a motion for summary judgment asking the court to dismiss the claim and in September 2014, the court granted the Company’s motion and dismissed all of the plaintiff’s claims with prejudice. The plaintiff has appealed the dismissal to the Court of Appeals for the Fifth Circuit. The Company intends to contest the appeal vigorously.
	Regulatory Matters
	The Company is subject to various possible claims and lawsuits regarding environmental matters. Management believes that costs, if any, related to these matters will not have a material adverse effect on the results of operations, cash flows or financial position of the Company.

Note_14_Reconciliation_of_Basi

Note 14 - Reconciliation of Basic and Diluted Per Share Data	9 Months Ended
	Sep. 30, 2014
Earnings Per Share [Abstract]	'
Earnings Per Share [Text Block]	'
	NOTE 14. RECONCILIATION OF BASIC AND DILUTED PER SHARE DATA (in thousands except per share date)
	Basic earnings per share is calculated by dividing net income allocated to common shares outstanding by the weighted average number of shares of common stock outstanding. Diluted earnings per share assumes the exercise of stock options provided the effect is not anti-dilutive.
	The Company grants certain incentive compensation awards, including restricted stock, to employees and non-employee directors that are considered to be participating securities. Due to the presence of participating securities, we have calculated our earnings per share using the two-class method.
	Three Months Ended September 30:	2014					2013
	Allocation of earnings:
	Net income	$	659				$	13,962
	Income allocated to participating securities		(19	)				(324	)
	Income allocated to common shares outstanding	$	640				$	13,638
	Weighted average common shares outstanding		20,637					20,150
	Basic earnings per share				0.03					0.68
	Stock options assumed exercised		621					612
	Weighted average diluted common shares and potential common share equivalents outstanding		21,258					20,762
	Diluted earnings per share				0.03					0.66
	Nine Months Ended September 30:	2014					2013
	Allocation of earnings:
	Net income	$	15,263				$	20,797
	Income allocated to participating securities		(402	)				(464	)
	Income allocated to common shares outstanding	$	14,861				$	20,333
	Weighted average common shares outstanding		20,474					19,801
	Basic earnings per share				0.73					1.03
	Stock options assumed exercised		648					719
	Weighted average diluted common shares and potential common share equivalents outstanding		21,122					20,520
	Diluted earnings per share				0.7					0.99
	Options to purchase the following number of shares of common stock (in thousands) were outstanding during the three and nine months ended September 30, 2014 and 2013 but were excluded from the computation of diluted earnings per share because the adjusted exercise prices of the options based upon the assumed proceeds were greater than the average market price of the shares during that period.
	Three Months Ended				Nine Months Ended
	September 30,				September 30,
	2014		2013		2014			2013
	25			130		125			150

Note_15_Components_of_Net_Peri

Note 15 - Components of Net Periodic Benefit Cost	9 Months Ended
	Sep. 30, 2014
Compensation and Retirement Disclosure [Abstract]	'
Pension and Other Postretirement Benefits Disclosure [Text Block]	'
	NOTE 15. COMPONENTS OF NET PERIODIC BENEFIT COST
		Three Months Ended						Nine Months Ended
		September 30,						September 30,
		2014			2013			2014			2013
		(in thousands)						(in thousands)
	Service cost	$	—		$	—		$	—		$	—
	Interest cost		274			248			822			744
	Expected return on plan assets		(298	)		(253	)		(894	)		(759	)
	Amortization of prior service costs		—			—			—			—
	Amortization of net loss		229			386			687			1,158
	Net periodic pension cost	$	205		$	381		$	615		$	1,143
	For the nine months ended September 30, 2014 and 2013, the Company contributed approximately $1.5 million and $1.4 million, respectively, to the Company’s pension plan. The Company expects to make contributions of $0.4 million to the pension plan during the remainder of 2014.
	In 2002, the Board of Directors authorized a plan to freeze the Company’s pension plan in accordance with ERISA rules and regulations so that new employees, after July 31, 2002, are not eligible to participate in the pension plan and further benefits no longer accrue for existing participants.

Note_16_Industry_Segments

Note 16 - Industry Segments	9 Months Ended
	Sep. 30, 2014
Segment Reporting [Abstract]	'
Segment Reporting Disclosure [Text Block]	'
	NOTE 16. INDUSTRY SEGMENTS
	The Company reports in two segments, animal nutrition and human nutrition. These segments are managed separately and information on each segment is provided to the chief operating decision makers as they make decisions about the Company’s overall resource allocation and assess performance.
	The animal nutrition segment is primarily comprised of the Company’s fishing related assets. These assets produce fish meal, oil and solubles that are sold primarily to animal nutrition customers. A portion of the Company’s fish oil is also partially refined and transferred at cost to the human nutrition segment where it is further refined and concentrated for sale to the human nutrition market. The human nutrition segment is comprised of assets used to produce, procure, market and sell product to human nutrition markets.
	The tables below present information about reported segments for three months ended September 30, 2014 and 2013 (in thousands). It should be noted that all cash and cash equivalent balances have been included in the identifiable assets of the unallocated segment.
	30-Sep-14		Animal			Human			Unallocated			Total
			Nutrition			Nutrition(1)
	Revenue (2)		$	55,123		$	15,641		$	—		$	70,764
	Cost of sales			40,920			15,666			—			56,586
	Gross profit			14,203			(25	)		—			14,178
	Selling, general and administrative expenses (including research and development)			540			2,985			7,299			10,824
	Loss related to plant closure			1,543			—			—			1,543
	Other (gains) and losses			12			—			—			12
	Operating income (loss)		$	12,108		$	(3,010	)	$	(7,299	)	$	1,799
	Depreciation and amortization		$	4,332		$	1,136		$	269		$	5,737
	Identifiable assets		$	233,239		$	167,838		$	2,579		$	403,656
	Capital expenditures		$	4,179		$	7,884		$	923		$	12,986
		-1	Includes revenues and related expenses for Bioriginal from September 5, 2014 through September 30, 2014.
		-2	Excludes revenue from internal customers of $0.4 million for fish oil that was transferred from the animal nutrition segment to the human nutrition segment at cost.
	30-Sep-13		Animal			Human			Unallocated			Total
			Nutrition			Nutrition
	Revenue (3)		$	79,828		$	7,792		$	—		$	87,620
	Cost of sales			52,321			5,879			—			58,200
	Gross profit			27,507			1,913			—			29,420
	Selling, general and administrative expenses (including research and development)			733			1,924			4,923			7,580
	Other (gains) and losses			(160	)		79			—			(81	)
	Operating income (loss)		$	26,934		$	(90	)	$	(4,923	)	$	21,921
	Depreciation and amortization		$	4,531		$	651		$	192		$	5,374
	Identifiable assets		$	271,363		$	54,095		$	1,323		$	326,781
	Capital expenditures		$	3,960		$	1,062		$	90		$	5,112
		-3	Excludes revenue from internal customers of $0.3 million for fish oil that was transferred from the animal nutrition segment to the human nutrition segment at cost.
	The tables below present information about reported segments for the nine months ended September 30, 2014 and 2013 (in thousands).
	30-Sep-14		Animal			Human			Unallocated			Total
			Nutrition			Nutrition(4)
	Revenue (5)		$	175,657		$	30,520		$	—		$	206,177
	Cost of sales			122,588			28,494			—			151,082
	Gross profit			53,069			2,026			—			55,095
	Selling, general and administrative expenses (including research and development)			1,729			6,973			15,769			24,471
	Loss related to plant closure			5,482			—			—			5,482
	Other (gains) and losses			54			191			—			245
	Operating income (loss)		$	45,804		$	(5,138	)	$	(15,769	)	$	24,897
	Depreciation and amortization		$	13,074		$	2,536		$	462		$	16,072
	Identifiable assets		$	233,239		$	167,838		$	2,579		$	403,656
	Capital expenditures		$	14,537		$	20,785		$	932		$	36,254
		-4	Includes revenues and related expenses for Bioriginal from September 5, 2014 through September 30, 2014.
		-5	Excludes revenue from internal customers of $1.8 million for fish oil that was transferred from the animal nutrition segment to the human nutrition segment at cost.
	30-Sep-13		Animal			Human			Unallocated			Total
			Nutrition			Nutrition(6)
	Revenue (7)		$	156,618		$	21,702		$	—		$	178,320
	Cost of sales			106,201			17,319			—			123,520
	Gross profit			50,417			4,383			—			54,800
	Selling, general and administrative expenses (including research and development)			2,023			5,081			14,069			21,173
	Other (gains) and losses			214			79			—			293
	Operating income (loss)		$	48,180		$	(777	)	$	(14,069	)	$	33,334
	Depreciation and amortization		$	13,352		$	1,721		$	554		$	15,627
	Identifiable assets		$	271,363		$	54,095		$	1,323		$	326,781
	Capital expenditures		$	16,006		$	1,675		$	328		$	18,009
		-6	Includes revenues and related expenses for WSP from February 27, 2013 through September 30, 2013.
		-7	Excludes revenue from internal customers of $1.3 million for fish oil that was transferred from the animal nutrition segment to the human nutrition segment at cost.
	A reconciliation of total segment operating income to total earnings from operations before income taxes for the three and nine months ended September 30, 2014 and 2013 is as follows (in thousands):
			Three Months Ended September 30,
			2014			2013
	Operating income for reportable segments		$	1,799		$	21,921
	Interest income			4			5
Interest expense			(365	)		(483	)
Gain on foreign currency			272			—
Other expense, net			(39	)		(104	)
Income before income taxes		$	1,671		$	21,339
		Nine Months Ended September 30,
		2014			2013
Operating income for reportable segments		$	24,897		$	33,334
Interest income			17			15
Interest expense			(747	)		(1,356	)
Gain on foreign currency			272			—
Other expense, net			(213	)		(285	)
Income before income taxes		$	24,226		$	31,708

Note_17_Fair_Value_Disclosures

Note 17 - Fair Value Disclosures	9 Months Ended
	Sep. 30, 2014
Fair Value Disclosures [Abstract]	'
Fair Value Disclosures [Text Block]	'
	NOTE 17. FAIR VALUE DISCLOSURES
	The following disclosures of the estimated fair value of financial instruments are made in accordance with the requirements of FASB ASC 825-10-50, Disclosure About Fair Value of Financial Instruments. The estimated fair value amounts have been determined by the Company using available market information and appropriate valuation methodologies.
	The carrying values and respective fair values of the Company’s long-term debt are presented below (in thousands). The fair value of the Company’s long-term debt is estimated based on the quoted market prices available to the Company for issuance of similar debt with similar terms at September 30, 2014 and December 31, 2013.
		September 30,		December 31,
		2014		2013
	Long-term Debt (Level 2):
	Carrying Value	$	54,927	$	24,242
	Estimated Fair Value	$	56,300	$	25,285
	The following tables set forth by level within the fair value hierarchy the Company's financial assets and liabilities that were accounted for at fair value on a recurring basis as of September 30, 2014 and December 31, 2013. As required by FASB ASC 820-10, financial assets and liabilities are classified in their entirety based on the lowest level of input that is significant to the fair value measurement. The Company's assessment of the significance of a particular input to the fair value measurement requires judgment, and may affect the valuation of fair value assets and liabilities and their placement within the fair value hierarchy levels.
		30-Sep-14
		Fair Value Measurements Using								Assets
										(Liabilities) at
		Level 1		Level 2			Level 3			Fair Value
	Assets (Liabilities) (in thousands)
	Energy swaps	$	—	$	(364	)	$	—	$	(364	)
	Total Assets (Liabilities)	$	—	$	(364	)	$	—	$	(364	)
		31-Dec-13
		Fair Value Measurements Using								Assets
										(Liabilities) at
		Level 1		Level 2			Level 3			Fair Value
	Assets (Liabilities) (in thousands)
	Energy swaps	$	—	$	275		$	—	$	275
	Total Assets (Liabilities)	$	—	$	275		$	—	$	275

Note_18_Income_Taxes

Note 18 - Income Taxes	9 Months Ended
	Sep. 30, 2014
Income Tax Disclosure [Abstract]	'
Income Tax Disclosure [Text Block]	'
	NOTE 18. INCOME TAXES
	The Company generally determines, with the exception of certain nonrecurring items, its periodic income tax benefit or expense based upon the current period income and the annual estimated tax rate for the Company adjusted for any change to prior period estimates. The estimated tax rate is revised, if necessary, as of the end of each successive interim period during the fiscal year to the Company’s current annual estimated tax rate.
	For the three months ended September 30, 2014, the income tax provision reflects an effective tax rate of 60.6%, compared to an effective tax rate of 34.6% for the quarter ended September 30, 2013. For the nine months ended September 30, 2014, the income tax provision reflects an effective tax rate of 37.0%, compared to an effective tax rate of 34.4% for the nine months ended September 30, 2013. The statutory tax rate of 35% for U.S. federal taxes was in effect for the three and nine months ended September 30, 2013 and 2014, respectively. The increase in the effective tax rates for the three and nine month periods ended September 30, 2014 is primarily a result of non-recurring expenses related to the acquisition of Bioriginal that were not deductible for tax purposes.

Accounting_Policies_by_Policy_

Accounting Policies, by Policy (Policies)	9 Months Ended
	Sep. 30, 2014
Accounting Policies [Abstract]	'
Basis of Accounting, Policy [Policy Text Block]	'
	Basis of Presentation
	These interim financial statements of the Company have been prepared in accordance with accounting principles generally accepted in the United States of America for interim financial information, the instructions to Quarterly Report on Form 10-Q and Rule 10-01 of Regulation S-X. Accordingly, certain information and footnote disclosures normally provided have been omitted. The interim financial statements should be read in conjunction with our Annual Report on Form 10-K for the year ended December 31, 2013. The year end condensed balance sheet data was derived from audited financial statements, but does not include all disclosures required by accounting principles generally accepted in the United States of America.
	In the opinion of management the accompanying unaudited condensed consolidated financial statements reflect all adjustments (consisting only of normal recurring adjustments) necessary for a fair statement of the Company’s consolidated financial position as of September 30, 2014, and the results of its operations for the three month and nine month periods ended September 30, 2014 and 2013 and its cash flows for the nine month periods ended September 30, 2014 and 2013. Operating results for interim periods are not necessarily indicative of the results that may be expected for the year ending December 31, 2014.
Consolidation, Policy [Policy Text Block]	'
	Consolidation
	The consolidated financial statements include the accounts of Omega Protein Corporation and its wholly owned subsidiaries. All significant intercompany accounts and transactions have been eliminated in consolidation.
Use of Estimates, Policy [Policy Text Block]	'
	Financial Statement Preparation
	The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the Company’s financial statements and the accompanying notes and the reported amounts of revenues and expenses during the reporting period. Actual amounts, when available, could differ from those estimates and those differences could have a material effect on the financial statements.
Revenue Recognition, Policy [Policy Text Block]	'
	Revenue Recognition
	The Company derives revenue principally from the sales of a variety of protein and oil products derived from menhaden. In addition and as a result of its acquisitions of Cyvex, InCon, WSP and Bioriginal the Company’s revenues include sales of dietary supplement and food ingredients and products. The Company recognizes revenue for the sale of its products when price is established, collectability is reasonably assured and risk and rewards of ownership of its products and title are transferred to the customer.
Shipping and Handling Cost, Policy [Policy Text Block]	'
	Shipping and Handling
	Amounts billed to customers associated with shipping and handling are included in revenues and the related costs are included in cost of sales.
Inventory, Policy [Policy Text Block]	'
	Inventories
	During the off-seasons, in connection with the upcoming fishing seasons, Omega Protein incurs costs (e.g., plant and vessel related labor, utilities, rent, repairs, and depreciation) that are directly related to Omega Protein’s infrastructure. These costs accumulate in inventory and are applied as elements of the cost of production of Omega Protein’s products throughout the fishing season ratably based on Omega Protein’s monthly units of production and the expected total units of production for the season.
	Any costs incurred during abnormal downtime related to activity at Omega Protein’s plants are charged to expense as incurred.
Derivatives, Policy [Policy Text Block]	'
	Energy Swap Agreements
	The Company does not enter into financial instruments for trading or speculative purposes. Omega Protein enters into energy swap agreements to manage portions of its cash flow exposure related to the volatility of natural gas, diesel and propane energy prices for its fish meal and fish oil production operations. The swaps effectively fix pricing for the quantities listed below during the consumption periods.
											(in thousands)
	Energy Swap		Consumption		Quantity		Price				Energy Swap				Deferred Tax
			Period				Per				Asset/(Liability)				Asset/(Liability)
							Unit				as of				as of
											September 30,				September 30,
											2014				2014
	Diesel - NYMEX Heating Oil Swap		Oct. – Nov., 2014		370,515 Gallons		$	2.92			$	(101	)		$	35
	Natural Gas - NYMEX Natural Gas Swap		Oct., 2014		41,258 MMBTUs		$	3.86				11				(4	)
	Propane – Natural Gas Liquids Swap		Oct. – Nov., 2014		190,000 Gallons		$	1.09				(9	)			3
	Diesel - NYMEX Heating Oil Swap		Apr. – Nov., 2015		1,667,116 Gallons		$	2.83				(237	)			83
	Natural Gas - NYMEX Natural Gas Swap		Apr. – Oct., 2015		114,000 MMBTUs		$	4.09				(28	)			10
											$	(364	)		$	127
											(in thousands)
	Energy Swap		Consumption		Quantity		Price				Energy Swap				Deferred Tax
			Period				Per				Asset/(Liability)				Asset/(Liability)
							Unit				as of				as of
											December 31,				December 31,
											2013				2013
	Diesel - NYMEX Heating Oil Swap		Oct. – Nov., 2013		998,700 Gallons		$	2.88			$	132			$	(46	)
	Natural Gas - NYMEX Natural Gas Swap		Apr. – Oct., 2014		307,374 MMBTUs		$	3.67				143				(50	)
											$	275			$	(96	)
	As of September 30, 2014, Omega Protein has recorded a long-term liability of $0.2 million net of the current portion included in other current liabilities of $0.2 million to recognize the fair value of energy swap derivatives, and has also recorded a deferred tax asset of $0.1 million associated therewith. As of December 31, 2013, Omega Protein has recorded a current asset in prepaid expenses of $0.3 to recognize the fair value of energy swap derivatives, and has also recorded a deferred tax liability of $0.1 million associated therewith. The effective portion of the change in fair value from inception to September 30, 2014 is recorded in “accumulated other comprehensive loss” in the Company’s consolidated financial statements. The following table illustrates the changes recorded, net of tax, in accumulated other comprehensive loss resulting from the energy swap agreements (in thousands).
			Three Months Ended								Nine Months Ended
			September 30,								September 30,
			2014				2013				2014				2013
	Beginning balance		$	142			$	(78	)		$	179			$	28
	Net (gain) loss, net of tax, reclassified to unallocated inventory cost pool			27				(92	)			(62	)			(108	)
	Net change associated with current period swap transactions, net of tax			(406	)			193				(354	)			103
	Ending balance		$	(237	)		$	23			$	(237	)		$	23
	The $0.2 million reported in accumulated other comprehensive loss as of September 30, 2014 will be reclassified to inventory in the period when the energy consumption takes place. The amount to be reclassified, net of taxes, during the next 12 months is expected to be approximately $0.1 million.
	The aggregate fair value of derivative instruments in gross asset positions as of September 30, 2014 and December 31, 2013 was $11,000 and $0.3 million. These amounts represent the maximum exposure to loss at the reporting date as a result of all of the counterparties failing to perform as contracted. This exposure could be reduced by up to $0.4 million and $0, respectively, of liabilities included in master netting arrangements with those same counterparties.
	As of September 30, 2014 (in thousands)		Gross				Gross				Net Amounts
			Amounts of				Amounts of				of Assets
			Recognized				Assets				(Liabilities)
			Assets				(Liabilities)				Presented in
			(Liabilities)				Offset				the Balance
											Sheet
	Energy swap derivatives – liability position		$	11			$	(375	)		$	(364	)
	As of December 31, 2013 (in thousands)		Gross				Gross				Net Amounts
			Amounts of				Amounts of				of Assets
			Recognized				Assets				(Liabilities)
			Assets				(Liabilities)				Presented in
			(Liabilities)				Offset				the Balance
											Sheet
	Energy swap derivatives – asset position		$	275			$	-			$	275
	If, at any time, the swaps are determined to be ineffective, in whole or in part, due to changes in the Company’s energy usage or underlying hedge agreements or assumptions, the fair value of the portion of the energy swaps determined to be ineffective will be recognized as a gain or loss in cost of sales for the applicable period. For the nine months ended September 30, 2013, the Company included an expense of $0.1 million in cost of sales resulting from transactions associated with the ineffectiveness of diesel energy swaps. See Note 17 – Fair Value Disclosures for additional information.
Costs Associated with Exit or Disposal Activities or Restructurings, Policy [Policy Text Block]	'
	Plant Closure
	Property, plant and equipment impairments related to the Cameron, Louisiana plant are made in accordance with the impairment of long-lived assets policy. Employee severance related charges have been recognized to the extent that the amount is probable, measurable and no-future service is expected or for those still employed, recognized pro-rata over the remaining service period. Ongoing clean-up and dismantlement costs will be recognized as incurred unless obligated and measureable by a contractual commitment. See Note 4 – Plant Closure for additional information related to the charges incurred.
Goodwill and Intangible Assets, Policy [Policy Text Block]	'
	Acquisitions, Goodwill and Other Intangible Assets
	All of the Company’s goodwill and other intangible assets are the result of acquisitions in the human nutrition segment. This segment is comprised of three reporting units, 1) InCon and Cyvex collectively, 2) WSP and 3) Bioriginal. The Company has recorded goodwill and certain other identifiable intangible assets that are more fully explained in Note 3 – Acquisition of Wisconsin Specialty Protein, L.L.C., Note 2 – Acquisition of Bioriginal Food & Science Corp. and Note 10 – Goodwill and Other Intangible Assets.
Comprehensive Income, Policy [Policy Text Block]	'
	Accumulated Other Comprehensive Loss
	The components of accumulated other comprehensive (loss) gain, net of tax, included in stockholders’ equity are as follows:
	Changes in Accumulated Other Comprehensive Loss by Component
	For the Nine Months Ended September 30, 2014 (in thousands)
			Gains and Losses					Defined Benefit					Foreign currency				Total
			On Cash Flow					Pension Items					Translation
			Hedges										adjustment
	Beginning balance December 31, 2013		$	179				$	(6,387	)			$	—			$	(6,208	)
	Other comprehensive loss before reclassifications			(354	)				—					(449	)			(803	)
	Amounts reclassified from accumulated other comprehensive loss			(62	)	(a)			446		(b)			—				384
	Net current-period other comprehensive income			(416	)				446					(449	)			(419	)
	Ending balance September 30, 2014		$	(237	)			$	(5,941	)			$	(449	)		$	(6,627	)
	Changes in Accumulated Other Comprehensive Loss by Component
	For the Nine Months Ended September 30, 2013 (in thousands)
			Gains and Losses					Defined Benefit					Total
			On Cash Flow					Pension Items
			Hedges
	Beginning balance December 31, 2012		$	28				$	(9,952	)			$	(9,924	)
	Other comprehensive loss before reclassifications			103					—					103
	Amounts reclassified from accumulated other comprehensive loss			(108	)	(a)			753		(b)			645
	Net current-period other comprehensive income			(5	)				753					748
	Ending balance September 30, 2013		$	23				$	(9,199	)			$	(9,176	)
		(a)	This accumulated other comprehensive income component is reclassified to the unallocated inventory cost pool in the period when the energy consumption takes place.
		(b)	This accumulated other comprehensive income component is included in the computation of net periodic pension costs as amortization of actuarial loss which are explained in more detail in Note 16 to the consolidated financial statements in Item 8 of the Company’s Form 10-K for the fiscal year ended December 31, 2013.
New Accounting Pronouncements, Policy [Policy Text Block]	'
	Recently Issued Accounting Standards
	In June 2014, the Financial Accounting Standards Board (the "FASB") issued Accounting Standards Update (ASU) No. 2014-12, Compensation — Stock Compensation (Topic 718), Accounting for Share-Based Payments When the Terms of an Award Provide That a Performance Target Could Be Achieved after the Requisite Service Period.  A performance target in a share-based payment that affects vesting and that could be achieved after the requisite service period should be accounted for as a performance condition under Accounting Standards Codification (ASC) 718, Compensation — Stock Compensation. As a result, the target is not reflected in the estimation of the award's grant date fair value. Compensation cost would be recognized over the required service period, if it is probable that the performance condition will be achieved.  The guidance is effective for annual periods beginning after December 15, 2015 and interim periods within those annual periods. Early adoption is permitted.  The Company does not expect this ASU to have a material impact on its Company’s consolidated results of operations, financial position and related disclosures.
	In May 2014, the FASB issued Accounting Standards Update (“ASU”) 2014-09, Revenue from Contracts with Customers.  This ASU amends the existing accounting standards for revenue recognition and is based on the principle that revenue should be recognized to depict the transfer of goods or services to a customer at an amount that reflects the consideration a company expects to receive in exchange for those goods or services.  The Company is required to adopt this ASU on January 1, 2017.  The Company does not expect this ASU to have a material impact on its Company’s consolidated results of operations, financial position and related disclosures.
	In April 2014, the FASB issued ASU No. 2014-08, Presentation of Financial Statements and Property, Plant and Equipment: Reporting Discontinued Operations and Disclosures of Disposals of Components of an Entity. This ASU changes the criteria for determining which disposals can be presented as discontinued operations and modifies related disclosure requirements. Under the new guidance, a discontinued operation is defined as a disposal of a component or group of components that is disposed of or is classified as held for sale and represents a strategic shift that has or will have a major effect on an entity's operations and financial results. The new standard is effective in annual periods beginning on or after December 15, 2014 with early adoption permitted. The guidance applies prospectively to new disposals and new classifications of disposal groups as held for sale after the effective date. The Company’s adoption of FASB ASU No. 2014-08 is not expected to impact on the Company’s consolidated results of operations, financial position and related disclosures.
	In July 2013, the FASB issued ASU No. 2013-11, Income Taxes: Presentation of an Unrecognized Tax Benefit When a Net Operating Loss Carryforward, a Similar Tax Loss, or a Tax Credit Carryforward Exists. This ASU amended the Income Taxes Topic of the Accounting Standards Codification to eliminate a diversity in practice for the presentation of unrecognized tax benefits when net operating loss carryforwards, similar tax losses or tax credit carryforwards exist. The amendment requires that the unrecognized tax benefit be presented as a reduction of the deferred tax assets associated with the carryforwards except in certain circumstances when it would be reflected as a liability. This guidance is effective for annual periods and interim periods within those annual periods beginning after December 15, 2013. The Company’s adoption of FASB ASU No. 2013-11 effective January 1, 2014 did not have an impact on the Company’s consolidated results of operations, financial position and related disclosures.
Foreign Currency Transactions and Translations Policy [Policy Text Block]	'
	Foreign Currency Translations
	All amounts are expressed in U.S. dollars unless otherwise indicated. The U.S. dollar is the functional currency of Bioriginal’s Canadian-based subsidiaries (“Bioriginal Canada”). Monetary assets and liabilities denominated in foreign currencies are translated into U.S. dollars at exchange rates in effect at the balance sheet date. Non-monetary items are translated at rates of exchange in effect when the assets were acquired or obligations incurred. Revenue and expenses are translated at average rates in effect in the period of the transaction. Foreign exchange gains and losses are included in the unaudited condensed consolidated statement of comprehensive income.
	The Euro is the functional currency of Bioriginal’s Netherlands-based subsidiaries (“Bioriginal Europe”). The operations of these subsidiaries are considered self-sustaining and their financial statements are translated into U.S. dollars using the current rate method. Under this method, all assets and liabilities are translated to U.S. dollars at exchange rates in effect at the balance sheet date and all revenue and expenses are translated at rates in effect at the time of the transactions. Exchange gains and losses arising from this translation, representing the net unrealized foreign currency translation gain (loss) on the Company's net investment in its self-sustaining subsidiaries, are recorded in the accumulated other comprehensive income (loss) component of shareholders' equity. Adjustments to the accumulated other comprehensive income (loss) account are not recorded in the unaudited condensed consolidated statement of comprehensive income until realized through a reduction in the Company's net investment in such operations.
Share-based Compensation, Option and Incentive Plans Policy [Policy Text Block]	'
	Stock-Based Compensation
	Stock Options
	The Company has a stock-based compensation plan, which is described in more detail in Note 16 to the consolidated financial statements in Item 8 of the Company’s Form 10-K for the fiscal year ended December 31, 2013. The Company has issued non-qualified stock options under its stock incentive plans. The options generally vested in equal installments over three years and expire in ten years.
	Net income for the three months ended September 30, 2013 includes $0.2 million ($0.1 million after-tax), respectively, of stock-based compensation costs related to stock options. Net income for the nine months ended September 30, 2013 includes $0.5 million ($0.3 million after-tax), respectively, of stock-based compensation costs related to stock options. The stock-based compensation costs related to stock options are recorded primarily in selling, general and administrative expenses in the unaudited condensed consolidated statement of comprehensive income. As of September 30, 2014 there was $0 of unrecognized compensation costs related to non-vested stock options that is expected to be recognized during the remainder of fiscal year 2014.
	Restricted Stock
	The Company has issued shares of restricted stock under the 2006 Incentive Plan. Shares of restricted stock generally vest on the third anniversary of the grant date or in equal installments over three years except for shares of restricted stock granted to non-employee directors which vest six months after the grant date. Non-vested shares are generally forfeited upon the termination of employment or service as a director. Holders of shares of restricted stock are entitled to all rights of a stockholder of the Company, including the right to vote the shares and receive any dividends or other distributions. The non-vested shares are considered participating securities and the Company has calculated earnings per share using the two-class method. See Note 14 – Reconciliation of Basic and Diluted Per Share Data.
	During the nine month periods ended September 30, 2014 and 2013, the Company issued 356,262 and 58,036 shares of restricted stock, respectively, under the 2006 Incentive Plan to employees and non-employee directors. The Company’s compensation expense related to restricted stock, which is primarily reflected in selling, general and administrative expenses in the unaudited condensed consolidated statement of comprehensive income, was approximately $0.6 million and $0.4 million ($0.4 million and $0.3 million after tax) for the three months ended September 30, 2014 and 2013, respectively. The Company’s compensation expense related to restricted stock was approximately $1.3 million and $1.0 million ($0.9 million and $0.6 million after tax) for the nine months ended September 30, 2014 and 2013, respectively. As of September 30, 2014, there was approximately $5.0 million ($3.2 million after tax) of unrecognized compensation expense related to non-vested restricted stock that is expected to be recognized over a weighted-average period of 1.4 years, of which $0.7 million ($0.5 million after-tax) of compensation expense is expected to be recognized during the remainder of fiscal year 2014.
	Performance Units
	On February 6, 2014, the Company adopted a cash incentive performance unit plan. The value of the units will be determined by reference to the performance of the Company’s common stock during the relevant performance period compared to the performance of the Russell 2000 Index member companies (the “Peer Group”) during that same period. One third of the Performance Units granted will be earned at the end of each calendar year of the performance period and will be valued for the calendar year based on the Total Shareholder Return (“TSR”) of the Company compared to the TSR of the Peer Group. The performance units contain a service provision of approximately 3 years and are liability-classified awards included in other long-term liabilities which are adjusted to fair value on a quarterly basis.
	The Company’s compensation expense related to performance units was approximately $0.1 million and $0.4 million for the three and nine months ended September 30, 2014, respectively, which is primarily reflected in selling, general and administrative expenses in the unaudited condensed consolidated statement of comprehensive income. As of September 30, 2014, there was approximately $1.2 million of unrecognized compensation cost related to performance units that is expected to be recognized over the next 2.25 years, of which $0.1 million of compensation expense is expected to be recognized during the remainder of fiscal year 2014.

Note_1_Significant_Accounting_1

Note 1 - Significant Accounting Policies Summary of Operations and Basis of Presentation (Tables)	9 Months Ended
	Sep. 30, 2014
Note 1 - Significant Accounting Policies Summary of Operations and Basis of Presentation (Tables) [Line Items]	'
Schedule of Changes in Accumulated Other Comprehensive Loss, Net of Tax [Table Text Block]	'
		Three Months Ended								Nine Months Ended
		September 30,								September 30,
		2014				2013				2014				2013
	Beginning balance	$	142			$	(78	)		$	179			$	28
	Net (gain) loss, net of tax, reclassified to unallocated inventory cost pool		27				(92	)			(62	)			(108	)
	Net change associated with current period swap transactions, net of tax		(406	)			193				(354	)			103
	Ending balance	$	(237	)		$	23			$	(237	)		$	23
Offsetting Assets And Liabilities [Table Text Block]	'
	As of September 30, 2014 (in thousands)	Gross				Gross				Net Amounts
		Amounts of				Amounts of				of Assets
		Recognized				Assets				(Liabilities)
		Assets				(Liabilities)				Presented in
		(Liabilities)				Offset				the Balance
										Sheet
	Energy swap derivatives – liability position	$	11			$	(375	)		$	(364	)
	As of December 31, 2013 (in thousands)	Gross				Gross				Net Amounts
		Amounts of				Amounts of				of Assets
		Recognized				Assets				(Liabilities)
		Assets				(Liabilities)				Presented in
		(Liabilities)				Offset				the Balance
										Sheet
	Energy swap derivatives – asset position	$	275			$	-			$	275
Schedule of Accumulated Other Comprehensive Income (Loss) [Table Text Block]	'
	Changes in Accumulated Other Comprehensive Loss by Component
	For the Nine Months Ended September 30, 2014 (in thousands)
		Gains and Losses					Defined Benefit					Foreign currency				Total
		On Cash Flow					Pension Items					Translation
		Hedges										adjustment
	Beginning balance December 31, 2013	$	179				$	(6,387	)			$	—			$	(6,208	)
	Other comprehensive loss before reclassifications		(354	)				—					(449	)			(803	)
	Amounts reclassified from accumulated other comprehensive loss		(62	)	(a)			446		(b)			—				384
	Net current-period other comprehensive income		(416	)				446					(449	)			(419	)
	Ending balance September 30, 2014	$	(237	)			$	(5,941	)			$	(449	)		$	(6,627	)
	Changes in Accumulated Other Comprehensive Loss by Component
	For the Nine Months Ended September 30, 2013 (in thousands)
		Gains and Losses					Defined Benefit					Total
		On Cash Flow					Pension Items
		Hedges
	Beginning balance December 31, 2012	$	28				$	(9,952	)			$	(9,924	)
	Other comprehensive loss before reclassifications		103					—					103
	Amounts reclassified from accumulated other comprehensive loss		(108	)	(a)			753		(b)			645
	Net current-period other comprehensive income		(5	)				753					748
	Ending balance September 30, 2013	$	23				$	(9,199	)			$	(9,176	)
Energy Swap [Member]	'
Note 1 - Significant Accounting Policies Summary of Operations and Basis of Presentation (Tables) [Line Items]	'
Schedule of Derivative Instruments [Table Text Block]	'
										(in thousands)
	Energy Swap	Consumption		Quantity		Price				Energy Swap				Deferred Tax
		Period				Per				Asset/(Liability)				Asset/(Liability)
						Unit				as of				as of
										September 30,				September 30,
										2014				2014
	Diesel - NYMEX Heating Oil Swap	Oct. – Nov., 2014		370,515 Gallons		$	2.92			$	(101	)		$	35
	Natural Gas - NYMEX Natural Gas Swap	Oct., 2014		41,258 MMBTUs		$	3.86				11				(4	)
	Propane – Natural Gas Liquids Swap	Oct. – Nov., 2014		190,000 Gallons		$	1.09				(9	)			3
	Diesel - NYMEX Heating Oil Swap	Apr. – Nov., 2015		1,667,116 Gallons		$	2.83				(237	)			83
	Natural Gas - NYMEX Natural Gas Swap	Apr. – Oct., 2015		114,000 MMBTUs		$	4.09				(28	)			10
										$	(364	)		$	127
										(in thousands)
	Energy Swap	Consumption		Quantity		Price				Energy Swap				Deferred Tax
		Period				Per				Asset/(Liability)				Asset/(Liability)
						Unit				as of				as of
										December 31,				December 31,
										2013				2013
	Diesel - NYMEX Heating Oil Swap	Oct. – Nov., 2013		998,700 Gallons		$	2.88			$	132			$	(46	)
	Natural Gas - NYMEX Natural Gas Swap	Apr. – Oct., 2014		307,374 MMBTUs		$	3.67				143				(50	)
										$	275			$	(96	)

Note_2_Acquisition_of_Biorigin1

Note 2 - Acquisition of Bioriginal Food & Science Corp. (Tables)	9 Months Ended
	Sep. 30, 2014
Bioriginal [Member]	'
Note 2 - Acquisition of Bioriginal Food & Science Corp. (Tables) [Line Items]	'
Schedule of Recognized Identified Assets Acquired and Liabilities Assumed [Table Text Block]	'
		(in thousands)
	Cash	$	93
	Accounts receivable, net		15,072
	Inventories		20,309
	Other current assets, net including prepaid expenses		1,820
	Property, plant, and equipment, net		3,026
	Identifiable intangible assets (a)		14,136
	Liabilities assumed		(39,249	)
	Total identifiable net assets		15,207
	Goodwill		31,274
	Total consideration	$	46,481
Business Acquisition, Pro Forma Information [Table Text Block]	'
		Revenue			Net income (loss)
		(in thousands)
	Bioriginal from September 5, 2014 – September 30, 2014	$	7,723		$	(281	)
	2014 supplemental pro forma from July 1, 2014 – September 30, 2014	$	91,842		$	1,055
	2014 supplemental pro forma from January 1, 2014 – September 30, 2014	$	289,174		$	17,582
	2013 supplemental pro forma from July 1, 2013 – September 30, 2013	$	113,519		$	14,825
	2013 supplemental pro forma from January 1, 2013 – September 30, 2013	$	259,509		$	23,674
Wisconsin Specialty Protein [Member]	'
Note 2 - Acquisition of Bioriginal Food & Science Corp. (Tables) [Line Items]	'
Schedule of Recognized Identified Assets Acquired and Liabilities Assumed [Table Text Block]	'
		(in thousands)
	Cash	$	403
	Other current assets, net including receivables, prepaid and inventory		2,515
	Property, plant, and equipment, net		14,095
	Identifiable intangible assets (a)		4,448
	Liabilities assumed		(5,996	)
	Total identifiable net assets		15,465
	Goodwill		11,614
	Total consideration	$	27,079
Business Acquisition, Pro Forma Information [Table Text Block]	'
		Revenue			Net income (loss)
		(in thousands)
	WSP from February 27, 2013 – September 30, 2013	$	6,603		$	(35	)
	2013 supplemental pro forma from January 1, 2013 – September 30, 2013	$	180,388		$	20,800

Note_4_Plant_Closure_Tables

Note 4 - Plant Closure (Tables)	9 Months Ended
	Sep. 30, 2014
Disposal Groups Plant Closure Disclsoure [Abstract]	'
Schedule of Disposal Group, Plant Closure Disposal [Table Text Block]	'
		Three Months		Nine Months		Cumulative to
		Ended		Ended		Date
		September 30,		September 30,
		2014		2014
		(in thousands)
	Impairment and relocation of property, plant and equipment	$	675	$	2,414	$	7,210
	Write-off material and supplies inventory		26		43		140
	Employee severance costs		100		340		685
	Estimated decommissioning costs		—		—		250
	Other ongoing closure costs not attributable to future production		742		2,685		3,794
	Total loss related to plant closure	$	1,543	$	5,482	$	12,079

Note_5_Receivables_Net_Tables

Note 5 - Receivables, Net (Tables)	9 Months Ended
	Sep. 30, 2014
Receivables [Abstract]	'
Schedule of Accounts, Notes, Loans and Financing Receivable [Table Text Block]	'
		September			December 31,
		30, 2014			2013
		(in thousands)
	Trade	$	44,282		$	18,689
	Insurance		1,728			1,806
	Income tax		1,259			714
	Other		135			310
	Total accounts receivable		47,404			21,519
	Less allowance for doubtful accounts		(1,305	)		(379	)
	Receivables, net	$	46,099		$	21,140

Note_6_Inventory_Tables

Note 6 - Inventory (Tables)	9 Months Ended
	Sep. 30, 2014
Inventory Disclosure [Abstract]	'
Schedule of Inventory, Current [Table Text Block]	'
		September 30,		December 31,		September 30,
		2014		2013		2013
		(in thousands)
	Fish meal	$	46,544	$	30,119	$	35,130
	Fish oil		25,458		41,081		40,186
	Fish solubles		708		2,599		2,777
	Nutraceutical products		4,141		3,650		4,563
	Bioriginal products		19,089		—		—
	Dairy protein products		2,072		1,355		1,484
	Unallocated inventory cost pool (including off-season costs)		242		6,655		(4,062	)
	Other materials and supplies		9,665		8,880		10,203
	Total inventory	$	107,919	$	94,339	$	90,281

Note_7_Prepaid_Expenses_and_Ot1

Note 7 - Prepaid Expenses and Other Current Assets (Tables)	9 Months Ended
	Sep. 30, 2014
Disclosure Text Block Supplement [Abstract]	'
Schedule of Other Current Assets [Table Text Block]	'
		September 30,		December 31,
		2014		2013
		(in thousands)
	Prepaid insurance	$	2,749	$	2,422
	Selling expenses		1,236		869
	Fair market value of energy swaps, current portion		11		275
	Whey process filters		98		38
	Leases		228		53
	Other prepaids and expenses		1,589		258
	Total prepaid expenses and other current assets	$	5,911	$	3,915

Note_8_Other_Assets_Tables

Note 8 - Other Assets (Tables)	9 Months Ended
	Sep. 30, 2014
Disclosure Text Block Supplement [Abstract]	'
Schedule of Other Assets [Table Text Block]	'
		September 30,		December 31,
		2014		2013
		(in thousands)
	Fish nets, net of accumulated amortization of $2,377 and $2,610	$	1,420	$	1,517
	Insurance receivable		424		3,048
	Title XI debt issuance costs		249		272
	Other debt issuance costs		283		299
	Deposits and other		290		98
	Total other assets, net	$	2,666	$	5,234

Note_9_Property_Plant_and_Equi1

Note 9 - Property, Plant, and Equipment (Tables)	9 Months Ended
	Sep. 30, 2014
Property, Plant and Equipment [Abstract]	'
Property, Plant and Equipment [Table Text Block]	'
		September 30,			December 31,
		2014			2013
		(in thousands)
	Land	$	9,087		$	7,457
	Plant assets		185,986			159,337
	Fishing vessels		111,675			101,745
	Furniture and fixtures		7,655			7,091
	Construction in progress		14,609			16,846
	Total property and equipment		329,012			292,476
	Less accumulated depreciation and impairment		(163,483	)		(148,363	)
	Property, plant and equipment, net	$	165,529		$	144,113

Note_10_Goodwill_and_Other_Int1

Note 10 - Goodwill and Other Intangible Assets (Tables)	9 Months Ended
	Sep. 30, 2014
Goodwill and Intangible Assets Disclosure [Abstract]	'
Schedule of Goodwill [Table Text Block]	'
		Bioriginal			WSP			Cyvex and		Total
								Incon
	1-Jan-14	$	—			11,614			7,986	$	19,600
	Acquisitions		31,274			—			—		31,274
	Foreign currency translation adjustment		(216	)		—			—		(216	)
	30-Sep-14	$	31,058			11,614			7,986	$	50,658
Schedule of Intangible Assets other than Goodwill [Table Text Block]	'
		September 30,			December 31,			Weighted
		2014			2013			Average
								Life (years)
	Carrying value of intangible assets subject to amortization:
	Customer relationships and non-competes	$	16,161		$	5,930
	Less accumulated amortization		(1,199	)		(613	)		10
	Total intangible assets subject to amortization, net	$	14,962		$	5,317
	Indefinite life intangible assets – trade names/secrets and other		6,426			2,615
	Total intangible assets	$	21,388		$	7,932
Schedule of Finite-Lived Intangible Assets, Future Amortization Expense [Table Text Block]	'
	Remainder of 2014	$	419
	2015		1,669
	2016		1,669
	2017		1,669
	Thereafter		9,536
	Total estimated future amortization expense	$	14,962

Note_11_Notes_Payable_and_Long1

Note 11 - Notes Payable and Long-Term Debt (Tables)	9 Months Ended
	Sep. 30, 2014
Disclosure Text Block [Abstract]	'
Schedule of Debt [Table Text Block]	'
		September 30,			December 31,
		2014			2013
		(in thousands)
	U.S. government guaranteed obligations (Title XI loans) collateralized by a first lien on certain vessels and certain plant assets:
	Amounts due in installments through 2025, interest from 5.7% to 7.0%	$	21,761		$	24,211
	Amounts due in installments through 2014, interest at Eurodollar rates plus 0.5% (0.7% at December 31, 2013)		—			31
	Amounts due on Loan Agreement in March 2017, interest at LIBOR plus an applicable rate (1.74% to 1.84% at September 30, 2014)		17,000			—
	ING credit facility, interest at EURIBOR plus an applicable rate (2.98% at September 30, 2014)		—			—
	ING Commercial Finance B.V., interest at EURIBOR plus an applicable rate (1.76% at September 30, 2014)		2,214			—
	HSBC credit facility, matures March 2019, interest at HSBC prime rate plus an applicable rate (4.5% at September 30, 2014)		7,558			—
	HSBC demand loan, amounts due in installments through March 2019, interest at HSBC’s Prime rate plus an applicable rate (currently 6.75%)		6,394			—
	Total debt		54,927			24,242
	Less current maturities		(14,157	)		(3,112	)
	Long-term debt	$	40,770		$	21,130

Note_12_Accrued_Liabilities_Ta

Note 12 - Accrued Liabilities (Tables)	9 Months Ended
	Sep. 30, 2014
Disclosure Text Block Supplement [Abstract]	'
Schedule of Accrued Liabilities [Table Text Block]	'
		September 30,		December 31,
		2014		2013
		(in thousands)
	Insurance	$	5,689	$	7,222
	Reserve for plant closure costs		542		595
	Salary and benefits		14,392		9,423
	Trade creditors		6,136		5,100
	Taxes, other than income tax		1,480		64
	Income tax		2,819		4,132
	Deferred revenue		6,929		2,362
	Accrued interest		201		200
	Other		260		47
	Total accrued liabilities	$	38,448	$	29,145

Note_14_Reconciliation_of_Basi1

Note 14 - Reconciliation of Basic and Diluted Per Share Data (Tables)	9 Months Ended
	Sep. 30, 2014
Earnings Per Share [Abstract]	'
Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]	'
	Three Months Ended September 30:	2014					2013
	Allocation of earnings:
	Net income	$	659				$	13,962
	Income allocated to participating securities		(19	)				(324	)
	Income allocated to common shares outstanding	$	640				$	13,638
	Weighted average common shares outstanding		20,637					20,150
	Basic earnings per share				0.03					0.68
	Stock options assumed exercised		621					612
	Weighted average diluted common shares and potential common share equivalents outstanding		21,258					20,762
	Diluted earnings per share				0.03					0.66
	Nine Months Ended September 30:	2014					2013
	Allocation of earnings:
	Net income	$	15,263				$	20,797
	Income allocated to participating securities		(402	)				(464	)
	Income allocated to common shares outstanding	$	14,861				$	20,333
	Weighted average common shares outstanding		20,474					19,801
	Basic earnings per share				0.73					1.03
	Stock options assumed exercised		648					719
	Weighted average diluted common shares and potential common share equivalents outstanding		21,122					20,520
	Diluted earnings per share				0.7					0.99
Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table Text Block]	'
	Three Months Ended				Nine Months Ended
	September 30,				September 30,
	2014		2013		2014			2013
	25			130		125			150

Note_15_Components_of_Net_Peri1

Note 15 - Components of Net Periodic Benefit Cost (Tables)	9 Months Ended
	Sep. 30, 2014
Compensation and Retirement Disclosure [Abstract]	'
Schedule of Net Benefit Costs [Table Text Block]	'
		Three Months Ended						Nine Months Ended
		September 30,						September 30,
		2014			2013			2014			2013
		(in thousands)						(in thousands)
	Service cost	$	—		$	—		$	—		$	—
	Interest cost		274			248			822			744
	Expected return on plan assets		(298	)		(253	)		(894	)		(759	)
	Amortization of prior service costs		—			—			—			—
	Amortization of net loss		229			386			687			1,158
	Net periodic pension cost	$	205		$	381		$	615		$	1,143

Note_16_Industry_Segments_Tabl

Note 16 - Industry Segments (Tables)	9 Months Ended
	Sep. 30, 2014
Segment Reporting [Abstract]	'
Schedule of Segment Reporting Information, by Segment [Table Text Block]	'
	30-Sep-14	Animal			Human			Unallocated			Total
		Nutrition			Nutrition(1)
	Revenue (2)	$	55,123		$	15,641		$	—		$	70,764
	Cost of sales		40,920			15,666			—			56,586
	Gross profit		14,203			(25	)		—			14,178
	Selling, general and administrative expenses (including research and development)		540			2,985			7,299			10,824
	Loss related to plant closure		1,543			—			—			1,543
	Other (gains) and losses		12			—			—			12
	Operating income (loss)	$	12,108		$	(3,010	)	$	(7,299	)	$	1,799
	Depreciation and amortization	$	4,332		$	1,136		$	269		$	5,737
	Identifiable assets	$	233,239		$	167,838		$	2,579		$	403,656
	Capital expenditures	$	4,179		$	7,884		$	923		$	12,986
	30-Sep-13	Animal			Human			Unallocated			Total
		Nutrition			Nutrition
	Revenue (3)	$	79,828		$	7,792		$	—		$	87,620
	Cost of sales		52,321			5,879			—			58,200
	Gross profit		27,507			1,913			—			29,420
	Selling, general and administrative expenses (including research and development)		733			1,924			4,923			7,580
	Other (gains) and losses		(160	)		79			—			(81	)
	Operating income (loss)	$	26,934		$	(90	)	$	(4,923	)	$	21,921
	Depreciation and amortization	$	4,531		$	651		$	192		$	5,374
	Identifiable assets	$	271,363		$	54,095		$	1,323		$	326,781
	Capital expenditures	$	3,960		$	1,062		$	90		$	5,112
	30-Sep-14	Animal			Human			Unallocated			Total
		Nutrition			Nutrition(4)
	Revenue (5)	$	175,657		$	30,520		$	—		$	206,177
	Cost of sales		122,588			28,494			—			151,082
	Gross profit		53,069			2,026			—			55,095
	Selling, general and administrative expenses (including research and development)		1,729			6,973			15,769			24,471
	Loss related to plant closure		5,482			—			—			5,482
	Other (gains) and losses		54			191			—			245
	Operating income (loss)	$	45,804		$	(5,138	)	$	(15,769	)	$	24,897
	Depreciation and amortization	$	13,074		$	2,536		$	462		$	16,072
	Identifiable assets	$	233,239		$	167,838		$	2,579		$	403,656
	Capital expenditures	$	14,537		$	20,785		$	932		$	36,254
	30-Sep-13	Animal			Human			Unallocated			Total
		Nutrition			Nutrition(6)
	Revenue (7)	$	156,618		$	21,702		$	—		$	178,320
	Cost of sales		106,201			17,319			—			123,520
	Gross profit		50,417			4,383			—			54,800
	Selling, general and administrative expenses (including research and development)		2,023			5,081			14,069			21,173
	Other (gains) and losses		214			79			—			293
	Operating income (loss)	$	48,180		$	(777	)	$	(14,069	)	$	33,334
	Depreciation and amortization	$	13,352		$	1,721		$	554		$	15,627
	Identifiable assets	$	271,363		$	54,095		$	1,323		$	326,781
	Capital expenditures	$	16,006		$	1,675		$	328		$	18,009
Reconciliation of Operating Income to Total Earnings Before Income Taxes [Table Text Block]	'
		Three Months Ended September 30,
		2014			2013
	Operating income for reportable segments	$	1,799		$	21,921
	Interest income		4			5
	Interest expense		(365	)		(483	)
	Gain on foreign currency		272			—
	Other expense, net		(39	)		(104	)
	Income before income taxes	$	1,671		$	21,339
		Nine Months Ended September 30,
		2014			2013
	Operating income for reportable segments	$	24,897		$	33,334
	Interest income		17			15
	Interest expense		(747	)		(1,356	)
	Gain on foreign currency		272			—
	Other expense, net		(213	)		(285	)
	Income before income taxes	$	24,226		$	31,708

Note_17_Fair_Value_Disclosures1

Note 17 - Fair Value Disclosures (Tables)	9 Months Ended
	Sep. 30, 2014
Fair Value Disclosures [Abstract]	'
Schedule of Carrying Values and Estimated Fair Values of Debt Instruments [Table Text Block]	'
		September 30,		December 31,
		2014		2013
	Long-term Debt (Level 2):
	Carrying Value	$	54,927	$	24,242
	Estimated Fair Value	$	56,300	$	25,285
Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis [Table Text Block]	'
		30-Sep-14
		Fair Value Measurements Using								Assets
										(Liabilities) at
		Level 1		Level 2			Level 3			Fair Value
	Assets (Liabilities) (in thousands)
	Energy swaps	$	—	$	(364	)	$	—	$	(364	)
	Total Assets (Liabilities)	$	—	$	(364	)	$	—	$	(364	)
		31-Dec-13
		Fair Value Measurements Using								Assets
										(Liabilities) at
		Level 1		Level 2			Level 3			Fair Value
	Assets (Liabilities) (in thousands)
	Energy swaps	$	—	$	275		$	—	$	275
	Total Assets (Liabilities)	$	—	$	275		$	—	$	275

Note_1_Significant_Accounting_2

Note 1 - Significant Accounting Policies Summary of Operations and Basis of Presentation (Details) (USD $)

3 Months Ended

9 Months Ended

12 Months Ended

3 Months Ended

9 Months Ended

3 Months Ended

9 Months Ended

3 Months Ended

9 Months Ended

3 Months Ended

9 Months Ended

9 Months Ended

Sep. 30, 2014

Sep. 30, 2013

Sep. 30, 2014

Sep. 30, 2013

Dec. 31, 2013

Dec. 31, 2012

Sep. 30, 2014

Dec. 31, 2013

Sep. 30, 2013

Sep. 30, 2014

Sep. 30, 2013

Dec. 31, 2014

Sep. 30, 2014

Sep. 30, 2014

Sep. 30, 2013

Sep. 30, 2014

Sep. 30, 2013

Dec. 31, 2014

Sep. 30, 2014

Sep. 30, 2014

Sep. 30, 2014

Sep. 30, 2014

Sep. 30, 2014

Sep. 30, 2013

Energy Swap [Member]

Energy Swap [Member]

Employee Stock Option [Member]

Employee Stock Option [Member]

Employee Stock Option [Member]

Restricted Stock [Member]

Restricted Stock [Member]

Restricted Stock [Member]

Restricted Stock [Member]

Restricted Stock [Member]

Restricted Stock [Member]

Performance Shares [Member]

Performance Shares [Member]

Performance Shares [Member]

Unallocated Inventory and Net Change with Current Period Swap Transaction [Member]

Animal Nutrition [Member]

Human Nutrition [Member]

Ineffective Portion of Diesel Energy Swaps [Member]

Scenario, Forecast [Member]

Non-Employee Directors [Member]

Scenario, Forecast [Member]

Note 1 - Significant Accounting Policies Summary of Operations and Basis of Presentation (Details) [Line Items]

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Number of Operating Segments

'

'

2

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Number of Subsidiaries

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

2

3

'

Numer of Product Lines

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

3

'

Derivative Liability, Noncurrent

'

'

'

'

'

'

$200,000

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Derivative Liability, Current

'

'

'

'

'

'

200,000

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Deferred Tax Assets, Derivative Instruments

'

'

'

'

'

'

100,000

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Derivative Asset, Current

11,000

'

11,000

'

275,000

'

'

300,000

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Deferred Tax Liabilities, Derivatives

-127,000

'

-127,000

'

96,000

'

'

100,000

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Accumulated Other Comprehensive Income (Loss), Cumulative Changes in Net Gain (Loss) from Cash Flow Hedges, Effect Net of Tax

-237,000

23,000

-237,000

23,000

179,000

28,000

'

'

'

'

'

'

'

'

'

'

'

'

'

'

-200,000

'

'

'

Accumulated Other Comprehensive Income Reclassified to Inventory Cost

100,000

'

100,000

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Derivative Asset, Fair Value, Gross Asset

11,000

'

11,000

'

275,000

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Derivative Asset, Fair Value, Gross Liability

375,000

'

375,000

'

0

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Cost of Goods and Services Sold

56,586,000

58,200,000

151,082,000

123,520,000

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

100,000

Number of Reporting Units

'

'

'

'

2

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

3

'

Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Period

'

'

'

'

'

'

'

'

'

'3 years

'

'

'6 months

'

'

'3 years

'

'

'

'3 years

'

'

'

'

Share-based Compensation Arrangement by Share-based Payment Award, Expiration Period

'

'

'

'

'

'

'

'

'

'10 years

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Allocated Share-based Compensation Expense

'

'

'

'

'

'

'

'

200,000

'

500,000

700,000

'

600,000

400,000

1,300,000

1,000,000

100,000

100,000

400,000

'

'

'

'

Allocated Share-based Compensation Expense, Net of Tax

'

'

'

'

'

'

'

'

100,000

'

300,000

500,000

'

400,000

300,000

900,000

600,000

'

'

'

'

'

'

'

Employee Service Share-based Compensation, Nonvested Awards, Compensation Cost Not yet Recognized

'

'

'

'

'

'

'

'

'

0

'

'

'

5,000,000

'

5,000,000

'

'

1,200,000

1,200,000

'

'

'

'

Stock Issued During Period, Shares, Restricted Stock Award, Gross (in Shares)

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

356,262

58,036

'

'

'

'

'

'

'

Employee Service Share-based Compensation, Nonvested Awards, Total Compensation Cost Not yet Recognized, Net

'

'

'

'

'

'

'

'

'

'

'

'

'

$3,200,000

'

$3,200,000

'

'

'

'

'

'

'

'

Employee Service Share-based Compensation, Nonvested Awards, Compensation Cost Not yet Recognized, Period for Recognition

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'1 year 146 days

'

'

'

'2 years 3 months

'

'

'

'

Note_1_Significant_Accounting_3

Note 1 - Significant Accounting Policies Summary of Operations and Basis of Presentation (Details) - Energy Swap Balances (USD $)	Sep. 30, 2014	Dec. 31, 2013	Sep. 30, 2014	Sep. 30, 2014	Dec. 31, 2013	Sep. 30, 2014	Sep. 30, 2014	Dec. 31, 2013	Sep. 30, 2014
In Thousands, unless otherwise specified			NYMEX Heating Oil Swap [Member]	NYMEX Heating Oil Swap [Member]	NYMEX Heating Oil Swap [Member]	NYMEX Natural Gas Swap [Member]	NYMEX Natural Gas Swap [Member]	NYMEX Natural Gas Swap [Member]	Natural Gas Liquids Swap [Member]
			October to November, 2014 [Member]	April to November, 2015 [Member]	October to November, 2013 [Member]	October, 2014 [Member]	April to October, 2015 [Member]	April to October, 2014 [Member]	October to November, 2014 [Member]
Derivative [Line Items]	'	'	'	'	'	'	'	'	'
Quantity	'	'	'370,515 Gallons	'1,667,116 Gallons	'998,700 Gallons	'41,258 MMBTUs	'114,000 MMBTUs	'307,374 MMBTUs	'190,000 Gallons
Price Per Unit (in Dollars per Item)	'	'	2.92	2.83	2.88	3.86	4.09	3.67	1.09
Energy Swap Asset/(Liability)	($364)	$275	($101)	($237)	$132	$11	($28)	$143	($9)
Deferred Tax Asset/(Liability)	$127	($96)	$35	$83	($46)	($4)	$10	($50)	$3

Note_1_Significant_Accounting_4

Note 1 - Significant Accounting Policies Summary of Operations and Basis of Presentation (Details) - Changes Recorded, Net of Tax, in Accumulated Other Comprehensive Loss Resulting From the Energy Swap Agreements (USD $)	3 Months Ended		9 Months Ended
In Thousands, unless otherwise specified	Sep. 30, 2014	Sep. 30, 2013	Sep. 30, 2014		Sep. 30, 2013
Note 1 - Significant Accounting Policies Summary of Operations and Basis of Presentation (Details) - Changes Recorded, Net of Tax, in Accumulated Other Comprehensive Loss Resulting From the Energy Swap Agreements [Line Items]	'	'	'		'
Balance as of	'	'	$179		$28
Net (gain) loss, net of tax, reclassified to unallocated inventory cost pool	'	'	-62	[1]	-108	[1]
Net change associated with current period swap transactions, net of tax	'	'	-354		103
Balance as of	-237	23	-237		23
Swap [Member] | Energy Related Derivative [Member]	'	'	'		'
Note 1 - Significant Accounting Policies Summary of Operations and Basis of Presentation (Details) - Changes Recorded, Net of Tax, in Accumulated Other Comprehensive Loss Resulting From the Energy Swap Agreements [Line Items]	'	'	'		'
Net change associated with current period swap transactions, net of tax	-406	193	-354		103
Energy Related Derivative [Member]	'	'	'		'
Note 1 - Significant Accounting Policies Summary of Operations and Basis of Presentation (Details) - Changes Recorded, Net of Tax, in Accumulated Other Comprehensive Loss Resulting From the Energy Swap Agreements [Line Items]	'	'	'		'
Balance as of	142	-78	179		28
Net (gain) loss, net of tax, reclassified to unallocated inventory cost pool	27	-92	-62		-108
Balance as of	($237)	$23	($237)		$23
[1]	This accumulated other comprehensive income component is reclassified to the unallocated inventory cost pool in the period when the energy consumption takes place.

Note_1_Significant_Accounting_5

Note 1 - Significant Accounting Policies Summary of Operations and Basis of Presentation (Details) - Gross Amounts, Gross Amounts Offset and Net Amounts of Assets Presented in Balance Sheet (USD $)	Sep. 30, 2014	Dec. 31, 2013
Gross Amounts, Gross Amounts Offset and Net Amounts of Assets Presented in Balance Sheet [Abstract]	'	'
Gross Amount of Recognized Assets (Liabilities)	$11,000	$275,000
Gross Amounts of Assets (Liabilities) Offset	-375,000	0
Net Amounts of Assets (Liabilities) Presented in the Balance Sheet	($364,000)	$275,000

Note_1_Significant_Accounting_6

Note 1 - Significant Accounting Policies Summary of Operations and Basis of Presentation (Details) - Changes in Accumulated Other Comprehensive Loss (USD $)	3 Months Ended		9 Months Ended
In Thousands, unless otherwise specified	Sep. 30, 2014	Sep. 30, 2013	Sep. 30, 2014		Sep. 30, 2013
Changes in Accumulated Other Comprehensive Loss [Abstract]	'	'	'		'
Balance as of	'	'	$179		$28
Balance as of	'	'	-6,387		-9,952
Balance as of	'	'	0		'
Balance as of	'	'	-6,208		-9,924
Other comprehensive loss before reclassifications	'	'	-354		103
Other comprehensive loss before reclassifications	'	'	-449		'
Other comprehensive loss before reclassifications	'	'	-803		103
Amounts reclassified from accumulated other comprehensive loss	'	'	-62	[1]	-108	[1]
Amounts reclassified from accumulated other comprehensive loss	'	'	446	[2]	753	[2]
Amounts reclassified from accumulated other comprehensive loss	'	'	384		645
Net current-period other comprehensive income	-379	101	-416		-5
Net current-period other comprehensive income	149	251	446		753
Net current-period other comprehensive income	-449	'	-449		'
Net current-period other comprehensive income	'	'	-419		748
Balance as of	-237	23	-237		23
Balance as of	-5,941	-9,199	-5,941		-9,199
Balance as of	-449	'	-449		'
Balance as of	($6,627)	($9,176)	($6,627)		($9,176)
[1]	This accumulated other comprehensive income component is reclassified to the unallocated inventory cost pool in the period when the energy consumption takes place.
[2]	This accumulated other comprehensive income component is included in the computation of net periodic pension costs as amortization of actuarial loss which are explained in more detail in Note 16 to the consolidated financial statements in Item 8 of the Company's Form 10-K for the fiscal year ended December 31, 2013.

Note_2_Acquisition_of_Biorigin2

Note 2 - Acquisition of Bioriginal Food & Science Corp. (Details)	0 Months Ended		1 Months Ended		0 Months Ended			1 Months Ended
	Sep. 05, 2014	Sep. 05, 2014	Feb. 28, 2013	Feb. 28, 2013	Sep. 05, 2014	Sep. 05, 2014	Sep. 05, 2014	Feb. 28, 2013
	Aggrgegate Purchase Price [Member]	Estimated Working Capital [Member]	Estimated Working Capital [Member]	Equity Purchase Price [Member]	Bioriginal [Member]	Bioriginal [Member]	Bioriginal [Member]	Wisconsin Specialty Protein [Member]
	Bioriginal [Member]	Bioriginal [Member]	Wisconsin Specialty Protein [Member]	Wisconsin Specialty Protein [Member]	USD ($)	USD ($)	CAD	USD ($)
	USD ($)	USD ($)	USD ($)	USD ($)
Note 2 - Acquisition of Bioriginal Food & Science Corp. (Details) [Line Items]	'	'	'	'	'	'	'	'
Business Combination, Consideration Transferred	$70,500,000	'	'	'	$46,481,000	'	'	$27,079,000
Payments to Acquire Businesses, Gross	'	700,000	600,000	26,500,000	46,500,000	'	'	'
Business Combination, Consideration Transferred, Liabilities Incurred	'	'	'	'	21,500,000	'	'	'
Business Acquisition, Equity Interest Issued or Issuable, Number of Shares (in Shares)	'	'	'	'	238,377	'	'	'
Business Acquisition, Equity Interest Issued or Issuable, Value Assigned	'	'	'	'	'	3,200,000	'	'
Business Combination, Contingent Consideration Arrangements, Range of Outcomes, Value, High (in Dollars)	'	'	'	'	'	'	8,800,000	'
Business Combination, Acquisition Related Costs	'	'	'	'	2,700,000	'	'	'
Business Acquisition, Percentage of Voting Interests Acquired	'	'	'	'	'	'	'	100.00%
Business Acquisition, Transaction Costs	'	'	'	'	'	'	'	$800,000

Note_2_Acquisition_of_Biorigin3

Note 2 - Acquisition of Bioriginal Food & Science Corp. (Details) - Fair Value of the Bioriginal Assets and Acquired Liabilities Assumed (USD $)	Sep. 30, 2014	Dec. 31, 2013	Sep. 05, 2014	Sep. 30, 2014	Sep. 05, 2014
In Thousands, unless otherwise specified			Bioriginal [Member]	Bioriginal [Member]	Bioriginal [Member]
Note 2 - Acquisition of Bioriginal Food & Science Corp. (Details) - Fair Value of the Bioriginal Assets and Acquired Liabilities Assumed [Line Items]	'	'	'	'	'
Cash	'	'	'	'	$93
Accounts receivable, net	'	'	'	'	15,072
Inventories	'	'	'	'	20,309
Other current assets, net including prepaid expenses	'	'	'	'	1,820
Property, plant, and equipment, net	'	'	'	'	3,026
Identifiable intangible assets (a)	'	'	'	'	14,136	[1]
Liabilities assumed	'	'	'	'	-39,249
Total identifiable net assets	'	'	'	'	15,207
Goodwill	50,658	19,600	'	31,058	31,274
Total consideration	'	'	$46,481	'	'
[1]	See Note 10 - Goodwill and Other Intangible Assets for weighted average lives.

Note_2_Acquisition_of_Biorigin4

Note 2 - Acquisition of Bioriginal Food & Science Corp. (Details) - Pro Forma Financial Information (Bioriginal [Member], USD $)	1 Months Ended	3 Months Ended		9 Months Ended
In Thousands, unless otherwise specified	Sep. 30, 2014	Sep. 30, 2014	Sep. 30, 2013	Sep. 30, 2014	Sep. 30, 2013
Bioriginal [Member]	'	'	'	'	'
Note 2 - Acquisition of Bioriginal Food & Science Corp. (Details) - Pro Forma Financial Information [Line Items]	'	'	'	'	'
Bioriginal from September 5, 2014 – September 30, 2014	$7,723	'	'	'	'
Bioriginal from September 5, 2014 – September 30, 2014	-281	'	'	'	'
Revenue	'	91,842	113,519	289,174	259,509
Net Income (loss)	'	$1,055	$14,825	$17,582	$23,674

Note_3_Acquisition_of_Wisconsi

Note 3 - Acquisition of Wisconsin Specialty Protein, L.L.C. (Details) - Fair Value of the Wisconsin Specialty Protein Assets and Acquired Liabilities Assumed (USD $)	1 Months Ended
In Thousands, unless otherwise specified	Feb. 28, 2013		Sep. 30, 2014	Dec. 31, 2013
Note 3 - Acquisition of Wisconsin Specialty Protein, L.L.C. (Details) - Fair Value of the Wisconsin Specialty Protein Assets and Acquired Liabilities Assumed [Line Items]	'		'	'
Goodwill	'		$50,658	$19,600
Wisconsin Specialty Protein [Member]	'		'	'
Note 3 - Acquisition of Wisconsin Specialty Protein, L.L.C. (Details) - Fair Value of the Wisconsin Specialty Protein Assets and Acquired Liabilities Assumed [Line Items]	'		'	'
Cash	403		'	'
Other current assets, net including receivables, prepaid and inventory	2,515		'	'
Property, plant, and equipment, net	14,095		'	'
Identifiable intangible assets (a)	4,448	[1]	'	'
Liabilities assumed	-5,996		'	'
Total identifiable net assets	15,465		'	'
Goodwill	11,614		11,614	11,614
Total consideration	$27,079		'	'
[1]	See Note 10 - Goodwill and Other Intangible Assets for weighted average lives.

Note_3_Acquisition_of_Wisconsi1

Note 3 - Acquisition of Wisconsin Specialty Protein, L.L.C. (Details) - Pro Forma Financial Information (Wisconsin Specialty Protein [Member], USD $)	7 Months Ended	9 Months Ended
In Thousands, unless otherwise specified	Sep. 30, 2013	Sep. 30, 2013
Wisconsin Specialty Protein [Member]	'	'
Note 3 - Acquisition of Wisconsin Specialty Protein, L.L.C. (Details) - Pro Forma Financial Information [Line Items]	'	'
WSP from February 27, 2013 – September 30, 2013	$6,603	'
WSP from February 27, 2013 – September 30, 2013	-35	'
2013 supplemental pro forma from January 1, 2013 – September 30, 2013	'	180,388
2013 supplemental pro forma from January 1, 2013 – September 30, 2013	'	$20,800

Note_4_Plant_Closure_Details_C

Note 4 - Plant Closure (Details) - Charges Incurred in Conjunction with Plant Closure (Cameron, Louisiana Menhaden Processing Plant [Member], USD $)	3 Months Ended	9 Months Ended	10 Months Ended
In Thousands, unless otherwise specified	Sep. 30, 2014	Sep. 30, 2014	Sep. 30, 2014
Cameron, Louisiana Menhaden Processing Plant [Member]	'	'	'
Note 4 - Plant Closure (Details) - Charges Incurred in Conjunction with Plant Closure [Line Items]	'	'	'
Impairment and relocation of property, plant and equipment	$675	$2,414	$7,210
Write-off material and supplies inventory	26	43	140
Employee severance costs	100	340	685
Estimated decommissioning costs	'	'	250
Other ongoing closure costs not attributable to future production	742	2,685	3,794
Total loss related to plant closure	$1,543	$5,482	$12,079

Note_5_Receivables_Net_Details

Note 5 - Receivables, Net (Details) - Receivables (USD $)	Sep. 30, 2014	Dec. 31, 2013
In Thousands, unless otherwise specified
Receivables [Abstract]	'	'
Trade	$44,282	$18,689
Insurance	1,728	1,806
Income tax	1,259	714
Other	135	310
Total accounts receivable	47,404	21,519
Less allowance for doubtful accounts	-1,305	-379
Receivables, net	$46,099	$21,140

Note_6_Inventory_Details_Class

Note 6 - Inventory (Details) - Classes of Inventory (USD $)	Sep. 30, 2014	Dec. 31, 2013	Sep. 30, 2013
In Thousands, unless otherwise specified
Inventory [Line Items]	'	'	'
Unallocated inventory cost pool (including off-season costs)	$242	$6,655	($4,062)
Other materials and supplies	9,665	8,880	10,203
Total inventory	107,919	94,339	90,281
Class, Fish Meal [Member]	'	'	'
Inventory [Line Items]	'	'	'
Inventory Goods	46,544	30,119	35,130
Class, Fish Oil [Member]	'	'	'
Inventory [Line Items]	'	'	'
Inventory Goods	25,458	41,081	40,186
Class, Fish Solubles [Member]	'	'	'
Inventory [Line Items]	'	'	'
Inventory Goods	708	2,599	2,777
Class, Nutraceutical Products [Member]	'	'	'
Inventory [Line Items]	'	'	'
Inventory Goods	4,141	3,650	4,563
Class, Bioriginal Essential Fatty Acid Products [Member]	'	'	'
Inventory [Line Items]	'	'	'
Inventory Goods	19,089	'	'
Class, Dairy Protein Products [Member]	'	'	'
Inventory [Line Items]	'	'	'
Inventory Goods	$2,072	$1,355	$1,484

Note_7_Prepaid_Expenses_and_Ot2

Note 7 - Prepaid Expenses and Other Current Assets (Details) - Prepaid Expenses and Other Current Assets (USD $)	Sep. 30, 2014	Dec. 31, 2013
In Thousands, unless otherwise specified
Prepaid Expenses and Other Current Assets [Abstract]	'	'
Prepaid insurance	$2,749	$2,422
Selling expenses	1,236	869
Fair market value of energy swaps, current portion	11	275
Whey process filters	98	38
Leases	228	53
Other prepaids and expenses	1,589	258
Total prepaid expenses and other current assets	$5,911	$3,915

Note_8_Other_Assets_Details

Note 8 - Other Assets (Details) (USD $)	3 Months Ended		9 Months Ended
In Millions, unless otherwise specified	Sep. 30, 2014	Sep. 30, 2013	Sep. 30, 2014	Sep. 30, 2013
Disclosure Text Block Supplement [Abstract]	'	'	'	'
Amortization	$0.30	$0.40	$1	$1

Note_8_Other_Assets_Details_Ot

Note 8 - Other Assets (Details) - Other Assets (USD $)	Sep. 30, 2014	Dec. 31, 2013
In Thousands, unless otherwise specified
Note 8 - Other Assets (Details) - Other Assets [Line Items]	'	'
Other Asset, Net	$2,666	$5,234
Insurance receivable	424	3,048
Property, Leased, Fishing Nets [Member]	'	'
Note 8 - Other Assets (Details) - Other Assets [Line Items]	'	'
Other Asset, Net	1,420	1,517
Title XI Debt Issuance Costs [Member]	'	'
Note 8 - Other Assets (Details) - Other Assets [Line Items]	'	'
Other Asset, Net	249	272
Other Debt Issuance Costs [Member]	'	'
Note 8 - Other Assets (Details) - Other Assets [Line Items]	'	'
Other Asset, Net	283	299
Deposits and Other [Member]	'	'
Note 8 - Other Assets (Details) - Other Assets [Line Items]	'	'
Other Asset, Net	$290	$98

Note_8_Other_Assets_Details_Ot1

Note 8 - Other Assets (Details) - Other Assets (Parentheticals) (Property, Leased, Fishing Nets [Member], USD $)	Sep. 30, 2014	Dec. 31, 2013
In Thousands, unless otherwise specified
Property, Leased, Fishing Nets [Member]	'	'
Note 8 - Other Assets (Details) - Other Assets (Parentheticals) [Line Items]	'	'
Fish nets, accumulated amortization	$2,377	$2,610

Note_9_Property_Plant_and_Equi2

Note 9 - Property, Plant, and Equipment (Details) (USD $)	3 Months Ended		9 Months Ended		3 Months Ended	9 Months Ended	10 Months Ended
	Sep. 30, 2014	Sep. 30, 2013	Sep. 30, 2014	Sep. 30, 2013	Sep. 30, 2014	Sep. 30, 2014	Sep. 30, 2014
					Cameron, Louisiana Menhaden Processing Plant [Member]	Cameron, Louisiana Menhaden Processing Plant [Member]	Cameron, Louisiana Menhaden Processing Plant [Member]
Note 9 - Property, Plant, and Equipment (Details) [Line Items]	'	'	'	'	'	'	'
Depreciation	$5,100,000	$4,800,000	$14,400,000	$14,100,000	'	'	'
Interest Costs Capitalized	100,000	100,000	500,000	200,000	'	'	'
Impairment of Long-Lived Assets to be Disposed of	'	'	'	'	$675,000	$2,414,000	$7,210,000

Note_9_Property_Plant_and_Equi3

Note 9 - Property, Plant, and Equipment (Details) - Property, Plant, and Equipment (USD $)	Sep. 30, 2014	Dec. 31, 2013
In Thousands, unless otherwise specified
Property, Plant and Equipment [Line Items]	'	'
Property, Plant, and Equipment	$329,012	$292,476
Less accumulated depreciation and impairment	-163,483	-148,363
Property, plant and equipment, net	165,529	144,113
Land [Member]	'	'
Property, Plant and Equipment [Line Items]	'	'
Property, Plant, and Equipment	9,087	7,457
Equipment, Plant [Member]	'	'
Property, Plant and Equipment [Line Items]	'	'
Property, Plant, and Equipment	185,986	159,337
Property, Fishing Vessels [Member]	'	'
Property, Plant and Equipment [Line Items]	'	'
Property, Plant, and Equipment	111,675	101,745
Furniture and Fixtures [Member]	'	'
Property, Plant and Equipment [Line Items]	'	'
Property, Plant, and Equipment	7,655	7,091
Construction in Progress [Member]	'	'
Property, Plant and Equipment [Line Items]	'	'
Property, Plant, and Equipment	$14,609	$16,846

Note_10_Goodwill_and_Other_Int2

Note 10 - Goodwill and Other Intangible Assets (Details) (USD $)	3 Months Ended		9 Months Ended		12 Months Ended
In Millions, unless otherwise specified	Sep. 30, 2014	Sep. 30, 2013	Sep. 30, 2014	Sep. 30, 2013	Dec. 31, 2013
Note 10 - Goodwill and Other Intangible Assets (Details) [Line Items]	'	'	'	'	'
Number of Reporting Units	'	'	'	'	2
Amortization of Intangible Assets	$0.30	$0.30	$0.60	$0.60	'
Trade Secrets [Member] | InCon [Member] | Indefinite-lived Intangible Assets [Member]	'	'	'	'	'
Note 10 - Goodwill and Other Intangible Assets (Details) [Line Items]	'	'	'	'	'
Fair Value in Excess of Carrying Value, Percentage	'	'	'	'	5.00%
Incon/Cyvex and WSP [Member] | Goodwill [Member]	'	'	'	'	'
Note 10 - Goodwill and Other Intangible Assets (Details) [Line Items]	'	'	'	'	'
Fair Value in Excess of Carrying Value, Percentage	'	'	'	'	21.00%

Note_10_Goodwill_and_Other_Int3

Note 10 - Goodwill and Other Intangible Assets (Details) - Changes in Carrying Amount of Goodwill Resulting from Company's Acquisitions (USD $)	9 Months Ended
In Thousands, unless otherwise specified	Sep. 30, 2014	Sep. 30, 2014	Sep. 05, 2014	Sep. 30, 2014	Dec. 31, 2013	Feb. 28, 2013	Sep. 30, 2014	Dec. 31, 2013
		Bioriginal [Member]	Bioriginal [Member]	Wisconsin Specialty Protein [Member]	Wisconsin Specialty Protein [Member]	Wisconsin Specialty Protein [Member]	Cyvex and Incon [Member]	Cyvex and Incon [Member]
Goodwill [Line Items]	'	'	'	'	'	'	'	'
1-Jan-14	$19,600	'	$31,274	$11,614	$11,614	$11,614	$7,986	$7,986
Acquisitions	31,274	31,274	'	'	'	'	'	'
Foreign currency translation adjustment	-216	-216	'	'	'	'	'	'
30-Sep-14	$50,658	$31,058	$31,274	$11,614	$11,614	$11,614	$7,986	$7,986

Note_10_Goodwill_and_Other_Int4

Note 10 - Goodwill and Other Intangible Assets (Details) - Table of Intangible Assets Other than Goodwill (USD $)	9 Months Ended
In Thousands, unless otherwise specified	Sep. 30, 2014	Dec. 31, 2013
Table of Intangible Assets Other than Goodwill [Abstract]	'	'
Customer relationships and non-competes	$16,161	$5,930
Less accumulated amortization	-1,199	-613
Less accumulated amortization	'10 years	'
Total intangible assets subject to amortization, net	14,962	5,317
Indefinite life intangible assets – trade names/secrets and other	6,426	2,615
Total intangible assets	$21,388	$7,932

Note_10_Goodwill_and_Other_Int5

Note 10 - Goodwill and Other Intangible Assets (Details) - Table of Future Amortization Expense (USD $)	Sep. 30, 2014	Dec. 31, 2013
In Thousands, unless otherwise specified
Table of Future Amortization Expense [Abstract]	'	'
Remainder of 2014	$419	'
2015	1,669	'
2016	1,669	'
2017	1,669	'
Thereafter	9,536	'
Total estimated future amortization expense	$14,962	$5,317

Note_11_Notes_Payable_and_Long2

Note 11 - Notes Payable and Long-Term Debt (Details)

Sep. 30, 2014

Dec. 31, 2013

Sep. 30, 2014

Jun. 20, 2011

Sep. 30, 2014

Dec. 31, 2013

Mar. 21, 2012

Sep. 30, 2014

Mar. 31, 2012

Apr. 15, 2014

Sep. 30, 2014

Sep. 30, 2014

Sep. 30, 2014

Mar. 31, 2012

Sep. 30, 2014

Apr. 15, 2014

Sep. 30, 2014

Apr. 15, 2014

Apr. 15, 2014

Apr. 15, 2014

Apr. 15, 2014

Sep. 30, 2014

Sep. 30, 2014

Apr. 15, 2014

USD ($)

USD ($)

Approval Letter [Member]

Approval Letter [Member]

Loan Agreement [Member]

Loan Agreement [Member]

Loan Agreement [Member]

Line of Credit [Member]

Line of Credit [Member]

Line of Credit [Member]

Line of Credit [Member]

Line of Credit [Member]

Line of Credit [Member]

Line of Credit [Member]

Line of Credit [Member]

Line of Credit [Member]

Letter of Credit [Member]

Letter of Credit [Member]

Cash Flow Loan [Member]

Cash Flow Loan [Member]

Cash Flow Loan [Member]

Cash Flow Loan [Member]

Bioriginal [Member]

Bioriginal [Member]

USD ($)

USD ($)

USD ($)

USD ($)

USD ($)

EURIBOR [Member]

EURIBOR [Member]

Prime Rate [Member]

Bioriginal [Member]

Bioriginal [Member]

Bioriginal [Member]

Bioriginal [Member]

Bioriginal [Member]

Bioriginal [Member]

Bioriginal [Member]

Bioriginal [Member]

Prime Rate [Member]

Prime Rate [Member]

Bioriginal [Member]

Bioriginal [Member]

HSBC Bank of Canada [Member]

HSBC Bank of Canada [Member]

Bioriginal [Member]

Bioriginal [Member]

Bioriginal [Member]

ING Bank N.V. [Member]

ING Bank N.V. [Member]

ING Commercial Finance B.V. [Member]

ING Commercial Finance B.V. [Member]

HSBC Bank of Canada [Member]

HSBC Bank of Canada [Member]

HSBC Bank of Canada [Member]

HSBC Bank of Canada [Member]

Minimum [Member]

Maximum [Member]

HSBC Bank of Canada [Member]

HSBC Bank of Canada [Member]

USD ($)

CAD

ING Bank N.V. [Member]

ING Commercial Finance B.V. [Member]

HSBC Bank of Canada [Member]

USD ($)

EUR (€)

USD ($)

CAD

USD ($)

USD ($)

Bioriginal [Member]

Bioriginal [Member]

CAD

USD ($)

HSBC Bank of Canada [Member]

HSBC Bank of Canada [Member]

Note 11 - Notes Payable and Long-Term Debt (Details) [Line Items]

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Line of Credit Facility, Maximum Borrowing Capacity

'

'

'

$10,000,000

$70,000,000

'

$60,000,000

'

'

'

'

€ 250,000

'

'

'

20,000,000

'

$4,200,000

'

'

'

'

'

'

Long-term Line of Credit

'

'

21,800,000

'

17,000,000

0

'

'

'

'

0

'

'

'

2,200,000

'

'

'

'

'

'

'

7,600,000

'

Line of Credit Facility, Maximum Borrowing Capacity Increase

'

'

'

'

10,000,000

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Letters of Credit Outstanding, Amount

3,500,000

3,500,000

'

'

'

'

'

'

'

'

'

'

'

'

'

'

4,200,000

'

'

'

'

'

'

'

Debt Instrument, Basis Spread on Variable Rate

'

'

'

'

'

'

'

2.97%

1.75%

1.25%

'

'

'

'

'

'

'

'

2.25%

4.25%

'

'

'

'

Line of Credit Facility, Interest Rate at Period End

'

'

'

'

'

'

'

'

'

'

2.98%

2.98%

1.76%

'

4.50%

'

'

'

'

'

'

'

'

'

Line of Credit Facility, Secured by Accounts Receivable, Maximum Percentage

'

'

'

'

'

'

'

'

'

'

'

'

'

85.00%

'

'

'

'

'

'

'

'

'

'

Line of Credit Facility, Secured by Inventory, Maximum Percentage

'

'

'

'

'

'

'

'

'

'

'

'

'

60.00%

'

'

'

'

'

'

'

'

'

'

Line of Credit Facility, Secured by Accounts Receivable and Inventory

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

17,000,000

'

'

'

'

'

'

'

'

Debt Instrument, Periodic Payment, Principal

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

166,700

'

'

'

Debt Instrument, Interest Rate, Effective Percentage

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

6.75%

'

'

Long-term Debt

54,927,000

24,242,000

'

'

17,000,000

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

6,400,000

'

'

Line of Credit Facility, Covenant, Funded Debt to EBITDA, Maximum

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

3

Line of Credit Facility, Covenant, Minimum Current Ratio

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

1.3

Line of Credit Facility, Covenant, Minimum Debt Service Coverage

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

1.25

Line of Credit Facility, Covenant, Maximum Capital Expenditures Aggegated in One Year

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

500,000

Line of Credit, Covenant, Maximum Funded Debt to EBITDA in order to Declare or Pay Dividends

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

2

Note_11_Notes_Payable_and_Long3

Note 11 - Notes Payable and Long-Term Debt (Details) - Table of Long-Term Debt (USD $)	Sep. 30, 2014	Dec. 31, 2013
In Thousands, unless otherwise specified
U.S. government guaranteed obligations (Title XI loans) collateralized by a first lien on certain vessels and certain plant assets:	'	'
Long-term debt gross	$54,927	$24,242
Less current maturities	-14,157	-3,112
Total debt	54,927	24,242
Less current maturities	-14,157	-3,112
Long-term debt	40,770	21,130
Installments Through 2025 [Member]	'	'
U.S. government guaranteed obligations (Title XI loans) collateralized by a first lien on certain vessels and certain plant assets:	'	'
Long-term debt gross	21,761	24,211
Total debt	21,761	24,211
Installments Through 2014 [Member]	'	'
U.S. government guaranteed obligations (Title XI loans) collateralized by a first lien on certain vessels and certain plant assets:	'	'
Long-term debt gross	'	31
Total debt	'	31
Loan Agreement [Member]	'	'
U.S. government guaranteed obligations (Title XI loans) collateralized by a first lien on certain vessels and certain plant assets:	'	'
Long-term debt gross	17,000	'
Total debt	17,000	'
ING Commercial Finance B.V Credit Facility [Member]	'	'
U.S. government guaranteed obligations (Title XI loans) collateralized by a first lien on certain vessels and certain plant assets:	'	'
Long-term debt gross	2,214	'
Total debt	2,214	'
HSBC Credit Facility [Member]	'	'
U.S. government guaranteed obligations (Title XI loans) collateralized by a first lien on certain vessels and certain plant assets:	'	'
Long-term debt gross	7,558	'
Total debt	7,558	'
HSBC Loan [Member]	'	'
U.S. government guaranteed obligations (Title XI loans) collateralized by a first lien on certain vessels and certain plant assets:	'	'
Long-term debt gross	6,394	'
Total debt	$6,394	'

Note_11_Notes_Payable_and_Long4

Note 11 - Notes Payable and Long-Term Debt (Details) - Table of Long-Term Debt (Parentheticals)	9 Months Ended	12 Months Ended
	Sep. 30, 2014	Dec. 31, 2013
Installments Through 2025 [Member] | Minimum [Member]	'	'
Note 11 - Notes Payable and Long-Term Debt (Details) - Table of Long-Term Debt (Parentheticals) [Line Items]	'	'
Interest Rate	5.70%	5.70%
Installments Through 2025 [Member] | Maximum [Member]	'	'
Note 11 - Notes Payable and Long-Term Debt (Details) - Table of Long-Term Debt (Parentheticals) [Line Items]	'	'
Interest Rate	7.00%	7.00%
Installments Through 2014 [Member] | Eurodollar [Member]	'	'
Note 11 - Notes Payable and Long-Term Debt (Details) - Table of Long-Term Debt (Parentheticals) [Line Items]	'	'
Variable Rate	0.50%	0.50%
Installments Through 2014 [Member]	'	'
Note 11 - Notes Payable and Long-Term Debt (Details) - Table of Long-Term Debt (Parentheticals) [Line Items]	'	'
Interest Rate	0.70%	0.70%
Loan Agreement [Member] | London Interbank Offered Rate (LIBOR) [Member] | Minimum [Member]	'	'
Note 11 - Notes Payable and Long-Term Debt (Details) - Table of Long-Term Debt (Parentheticals) [Line Items]	'	'
Variable Rate	1.74%	'
Loan Agreement [Member] | London Interbank Offered Rate (LIBOR) [Member] | Maximum [Member]	'	'
Note 11 - Notes Payable and Long-Term Debt (Details) - Table of Long-Term Debt (Parentheticals) [Line Items]	'	'
Variable Rate	1.84%	'
ING Credit Facility [Member] | EURIBOR [Member]	'	'
Note 11 - Notes Payable and Long-Term Debt (Details) - Table of Long-Term Debt (Parentheticals) [Line Items]	'	'
Variable Rate	2.98%	'
ING Commercial Finance B.V Credit Facility [Member] | EURIBOR [Member]	'	'
Note 11 - Notes Payable and Long-Term Debt (Details) - Table of Long-Term Debt (Parentheticals) [Line Items]	'	'
Variable Rate	1.76%	'
HSBC Credit Facility [Member] | Prime Rate [Member]	'	'
Note 11 - Notes Payable and Long-Term Debt (Details) - Table of Long-Term Debt (Parentheticals) [Line Items]	'	'
Variable Rate	4.50%	'
HSBC Loan [Member] | Prime Rate [Member]	'	'
Note 11 - Notes Payable and Long-Term Debt (Details) - Table of Long-Term Debt (Parentheticals) [Line Items]	'	'
Variable Rate	6.75%	'

Note_12_Accrued_Liabilities_De

Note 12 - Accrued Liabilities (Details) - Table of Accrued Liabilities (USD $)	Sep. 30, 2014	Dec. 31, 2013
In Thousands, unless otherwise specified
Table of Accrued Liabilities [Abstract]	'	'
Insurance	$5,689	$7,222
Reserve for plant closure costs	542	595
Salary and benefits	14,392	9,423
Trade creditors	6,136	5,100
Taxes, other than income tax	1,480	64
Income tax	2,819	4,132
Deferred revenue	6,929	2,362
Accrued interest	201	200
Other	260	47
Total accrued liabilities	$38,448	$29,145

Note_13_Commitments_and_Contin1

Note 13 - Commitments and Contingencies (Details)	Sep. 05, 2014	Sep. 05, 2014	Sep. 05, 2014	Sep. 05, 2014	Apr. 25, 2013	Apr. 25, 2013	Apr. 25, 2013
In Millions, unless otherwise specified	Annual Earnout Payment [Member]	Bioriginal [Member]	Bioriginal [Member]	Bioriginal [Member]	InCon [Member]	InCon [Member]	InCon [Member]
	Bioriginal [Member]		USD ($)	CAD	Earn-out Provision Base, EBITDA Range One [Member]	Earn-out Provision Base, EBITDA Range Two [Member]
	CAD				USD ($)	USD ($)
Note 13 - Commitments and Contingencies (Details) [Line Items]	'	'	'	'	'	'	'
Business Combination, Contingent Consideration Arrangements, Range of Outcomes, Value, Low	1.7	'	'	'	'	'	'
Business Combination, Contingent Consideration Arrangements, Range of Outcomes, Value, High	2.9	'	'	8.8	'	'	'
Business Combination, Contingent Consideration Arrangements, Term of Earn-out Payments	'	'3 years	'	'	'	'	'
Business Combination, Contingent Consideration, Liability	'	'	0.1	'	'	'	'
Changes in Earn-out	'	'	'	'	'	'	35.00%
Annual Earn Out Payments Percentage of EBITDA	'	'	'	'	3.25%	19.50%	'
Earnings Before Deduction Of Interest Tax And Amortization Expense	'	'	'	'	$3	$12	'

Note_14_Reconciliation_of_Basi2

Note 14 - Reconciliation of Basic and Diluted Per Share Data (Details) - Reconciliation of Basic and Diluted Per Share Data (USD $)	3 Months Ended		9 Months Ended
In Thousands, except Per Share data, unless otherwise specified	Sep. 30, 2014	Sep. 30, 2013	Sep. 30, 2014	Sep. 30, 2013
Allocation of earnings:	'	'	'	'
Net income	$659	$13,962	$15,263	$20,797
Income allocated to participating securities	-19	-324	-402	-464
Income allocated to common shares outstanding	$640	$13,638	$14,861	$20,333
Weighted average common shares outstanding	20,637	20,150	20,474	19,801
Basic earnings per share	$0.03	$0.68	$0.73	$1.03
Stock options assumed exercised	621	612	648	719
Weighted average diluted common shares and potential common share equivalents outstanding	21,258	20,762	21,122	20,520
Diluted earnings per share	$0.03	$0.66	$0.70	$0.99

Note_14_Reconciliation_of_Basi3

Note 14 - Reconciliation of Basic and Diluted Per Share Data (Details) - Outstanding Shares Excluded from Computation of Diluted Earnings Per Share	3 Months Ended		9 Months Ended
In Thousands, unless otherwise specified	Sep. 30, 2014	Sep. 30, 2013	Sep. 30, 2014	Sep. 30, 2013
Outstanding Shares Excluded from Computation of Diluted Earnings Per Share [Abstract]	'	'	'	'
	25	130	125	150

Note_15_Components_of_Net_Peri2

Note 15 - Components of Net Periodic Benefit Cost (Details) (USD $)	9 Months Ended
In Millions, unless otherwise specified	Sep. 30, 2014	Sep. 30, 2013
Compensation and Retirement Disclosure [Abstract]	'	'
Pension Contributions	$1.50	$1.40
Defined Benefit Plans, Estimated Future Employer Contributions in Current Fiscal Year	$0.40	'

Note_15_Components_of_Net_Peri3

Note 15 - Components of Net Periodic Benefit Cost (Details) - Summary of Components of Net Periodic Benefit Cost (USD $)	3 Months Ended		9 Months Ended
In Thousands, unless otherwise specified	Sep. 30, 2014	Sep. 30, 2013	Sep. 30, 2014	Sep. 30, 2013
Summary of Components of Net Periodic Benefit Cost [Abstract]	'	'	'	'
Interest cost	$274	$248	$822	$744
Expected return on plan assets	-298	-253	-894	-759
Amortization of net loss	229	386	687	1,158
Net periodic pension cost	$205	$381	$615	$1,143

Note_16_Industry_Segments_Deta

Note 16 - Industry Segments (Details) (USD $)	3 Months Ended				9 Months Ended
In Thousands, unless otherwise specified	Sep. 30, 2014		Sep. 30, 2013		Sep. 30, 2014		Sep. 30, 2013
Note 16 - Industry Segments (Details) [Line Items]	'		'		'		'
Number of Reportable Segments	'		'		2		'
Revenues	$70,764	[1]	$87,620	[2]	$206,177	[3]	$178,320	[4]
Transferred From Animal Nutrition To Human Nutrition Segment [Member]	'		'		'		'
Note 16 - Industry Segments (Details) [Line Items]	'		'		'		'
Revenues	$400		$300		$1,800		$1,300
[1]	Excludes revenue from internal customers of $0.4 million for fish oil that was transferred from the animal nutrition segment to the human nutrition segment at cost.
[2]	Excludes revenue from internal customers of $0.3 million for fish oil that was transferred from the animal nutrition segment to the human nutrition segment at cost.
[3]	Excludes revenue from internal customers of $1.8 million for fish oil that was transferred from the animal nutrition segment to the human nutrition segment at cost.
[4]	Excludes revenue from internal customers of $1.3 million for fish oil that was transferred from the animal nutrition segment to the human nutrition segment at cost.

Note_16_Industry_Segments_Deta1

Note 16 - Industry Segments (Details) - Reported Segments (USD $)	3 Months Ended				9 Months Ended
In Thousands, unless otherwise specified	Sep. 30, 2014		Sep. 30, 2013		Sep. 30, 2014		Sep. 30, 2013		Dec. 31, 2013
Segment Reporting Information [Line Items]	'		'		'		'		'
Revenue	$70,764	[1]	$87,620	[2]	$206,177	[3]	$178,320	[4]	'
Cost of sales	56,586		58,200		151,082		123,520		'
Gross profit	14,178		29,420		55,095		54,800		'
Selling, general and administrative expenses (including research and development)	10,824		7,580		24,471		21,173		'
Other (gains) and losses	12		-81		245		293		'
Operating income	1,799		21,921		24,897		33,334		'
Depreciation and amortization	5,737		5,374		16,072		15,627		'
Identifiable assets	403,656		326,781		403,656		326,781		331,394
Capital expenditures	12,986		5,112		36,254		18,009		'
Animal Nutrition [Member] | Plant Closure [Member]	'		'		'		'		'
Segment Reporting Information [Line Items]	'		'		'		'		'
Loss related to plant closure	1,543		'		5,482		'		'
Animal Nutrition [Member]	'		'		'		'		'
Segment Reporting Information [Line Items]	'		'		'		'		'
Revenue	55,123	[1]	79,828	[2]	175,657	[3]	156,618	[4]	'
Cost of sales	40,920		52,321		122,588		106,201		'
Gross profit	14,203		27,507		53,069		50,417		'
Selling, general and administrative expenses (including research and development)	540		733		1,729		2,023		'
Other (gains) and losses	12		-160		54		214		'
Operating income	12,108		26,934		45,804		48,180		'
Depreciation and amortization	4,332		4,531		13,074		13,352		'
Identifiable assets	233,239		271,363		233,239		271,363		'
Capital expenditures	4,179		3,960		14,537		16,006		'
Human Nutrition [Member] | Plant Closure [Member]	'		'		'		'		'
Segment Reporting Information [Line Items]	'		'		'		'		'
Loss related to plant closure	'	[5]	'		'	[5]	'		'
Human Nutrition [Member]	'		'		'		'		'
Segment Reporting Information [Line Items]	'		'		'		'		'
Revenue	15,641	[1],[5]	7,792	[2]	30,520	[3],[5]	21,702	[4],[6]	'
Cost of sales	15,666	[5]	5,879		28,494	[5]	17,319	[6]	'
Gross profit	-25	[5]	1,913		2,026	[5]	4,383	[6]	'
Selling, general and administrative expenses (including research and development)	2,985	[5]	1,924		6,973	[5]	5,081	[6]	'
Other (gains) and losses	'	[5]	79		191	[5]	79	[6]	'
Operating income	-3,010	[5]	-90		-5,138	[5]	-777	[6]	'
Depreciation and amortization	1,136	[5]	651		2,536	[5]	1,721	[6]	'
Identifiable assets	167,838	[5]	54,095	[6]	167,838	[5]	54,095	[6]	'
Capital expenditures	7,884	[5]	1,062		20,785	[5]	1,675	[6]	'
Unallocated [Member]	'		'		'		'		'
Segment Reporting Information [Line Items]	'		'		'		'		'
Revenue	'	[1]	'	[2]	'	[3]	'	[4]	'
Selling, general and administrative expenses (including research and development)	7,299		4,923		15,769		14,069		'
Operating income	-7,299		-4,923		-15,769		-14,069		'
Depreciation and amortization	269		192		462		554		'
Identifiable assets	2,579		1,323		2,579		1,323		'
Capital expenditures	923		90		932		328		'
Plant Closure [Member]	'		'		'		'		'
Segment Reporting Information [Line Items]	'		'		'		'		'
Loss related to plant closure	$1,543		'		$5,482		'		'
[1]	Excludes revenue from internal customers of $0.4 million for fish oil that was transferred from the animal nutrition segment to the human nutrition segment at cost.
[2]	Excludes revenue from internal customers of $0.3 million for fish oil that was transferred from the animal nutrition segment to the human nutrition segment at cost.
[3]	Excludes revenue from internal customers of $1.8 million for fish oil that was transferred from the animal nutrition segment to the human nutrition segment at cost.
[4]	Excludes revenue from internal customers of $1.3 million for fish oil that was transferred from the animal nutrition segment to the human nutrition segment at cost.
[5]	Includes revenues and related expenses for Bioriginal from September 5, 2014 through September 30, 2014.
[6]	Includes revenues and related expenses for WSP from February 27, 2013 through September 30, 2013.

Note_16_Industry_Segments_Deta2

Note 16 - Industry Segments (Details) - A Reconciliation of Total Segment Operating Income to Total Earnings from Operations Before Income Taxes (USD $)	3 Months Ended		9 Months Ended
In Thousands, unless otherwise specified	Sep. 30, 2014	Sep. 30, 2013	Sep. 30, 2014	Sep. 30, 2013
A Reconciliation of Total Segment Operating Income to Total Earnings from Operations Before Income Taxes [Abstract]	'	'	'	'
Operating income for reportable segments	$1,799	$21,921	$24,897	$33,334
Interest income	4	5	17	15
Interest expense	-365	-483	-747	-1,356
Gain on foreign currency	272	'	272	'
Other expense, net	-39	-104	-213	-285
Income before income taxes	$1,671	$21,339	$24,226	$31,708

Note_17_Fair_Value_Disclosures2

Note 17 - Fair Value Disclosures (Details) - Table of Long-Term Debt, Carrying Value and Fair Value (USD $)	Sep. 30, 2014	Dec. 31, 2013
In Thousands, unless otherwise specified
Table of Long-Term Debt, Carrying Value and Fair Value [Abstract]	'	'
Carrying Value	$54,927	$24,242
Estimated Fair Value	$56,300	$25,285

Note_17_Fair_Value_Disclosures3

Note 17 - Fair Value Disclosures (Details) - Table of Fair Value, Assets and Liabilities Accounted for on a Recurring Basis (USD $)	Sep. 30, 2014	Dec. 31, 2013
In Thousands, unless otherwise specified
Note 17 - Fair Value Disclosures (Details) - Table of Fair Value, Assets and Liabilities Accounted for on a Recurring Basis [Line Items]	'	'
Fair Value of derivative asset	($364)	$275
Energy Swap [Member] | Fair Value, Inputs, Level 1 [Member] | Fair Value, Measurements, Recurring [Member]	'	'
Note 17 - Fair Value Disclosures (Details) - Table of Fair Value, Assets and Liabilities Accounted for on a Recurring Basis [Line Items]	'	'
Fair Value of derivative asset	0	0
Energy Swap [Member] | Fair Value, Inputs, Level 2 [Member] | Fair Value, Measurements, Recurring [Member]	'	'
Note 17 - Fair Value Disclosures (Details) - Table of Fair Value, Assets and Liabilities Accounted for on a Recurring Basis [Line Items]	'	'
Fair Value of derivative asset	-364	275
Energy Swap [Member] | Fair Value, Inputs, Level 3 [Member] | Fair Value, Measurements, Recurring [Member]	'	'
Note 17 - Fair Value Disclosures (Details) - Table of Fair Value, Assets and Liabilities Accounted for on a Recurring Basis [Line Items]	'	'
Fair Value of derivative asset	0	0
Energy Swap [Member] | Fair Value, Measurements, Recurring [Member]	'	'
Note 17 - Fair Value Disclosures (Details) - Table of Fair Value, Assets and Liabilities Accounted for on a Recurring Basis [Line Items]	'	'
Fair Value of derivative asset	-364	275
Fair Value, Inputs, Level 1 [Member] | Fair Value, Measurements, Recurring [Member]	'	'
Note 17 - Fair Value Disclosures (Details) - Table of Fair Value, Assets and Liabilities Accounted for on a Recurring Basis [Line Items]	'	'
Fair Value of derivative asset	0	0
Fair Value, Inputs, Level 2 [Member] | Fair Value, Measurements, Recurring [Member]	'	'
Note 17 - Fair Value Disclosures (Details) - Table of Fair Value, Assets and Liabilities Accounted for on a Recurring Basis [Line Items]	'	'
Fair Value of derivative asset	-364	275
Fair Value, Inputs, Level 3 [Member] | Fair Value, Measurements, Recurring [Member]	'	'
Note 17 - Fair Value Disclosures (Details) - Table of Fair Value, Assets and Liabilities Accounted for on a Recurring Basis [Line Items]	'	'
Fair Value of derivative asset	0	0
Fair Value, Measurements, Recurring [Member]	'	'
Note 17 - Fair Value Disclosures (Details) - Table of Fair Value, Assets and Liabilities Accounted for on a Recurring Basis [Line Items]	'	'
Fair Value of derivative asset	($364)	$275

Note_18_Income_Taxes_Details

Note 18 - Income Taxes (Details)	3 Months Ended		9 Months Ended
	Sep. 30, 2014	Sep. 30, 2013	Sep. 30, 2014	Sep. 30, 2013
Income Tax Disclosure [Abstract]	'	'	'	'
Effective Income Tax Rate Reconciliation, Percent	60.60%	34.60%	37.00%	34.40%
Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent	35.00%	35.00%	35.00%	35.00%